Healthcare Administrative Automation

PaceMate is the United States counterpart to Implicity and the pair should be read together. Both aggregate cardiac implantable electronic device data across manufacturers and triage the resulting alert volume. Implicity approaches it as a regulated algorithm company with three cleared models and published sensitivity figures. PaceMate approaches it as a data and operations platform, and its strongest differentiators are commercial and security rather than clinical. PaceMateLIVE aggregates discrete device data, described as including serial numbers rather than only the summary fields, and pairs it with electronic health record data in one platform. The scope is broader than implanted devices alone: the company describes covering implantable cardiac devices, ambulatory event monitoring, heart failure monitoring and consumer electrocardiograms in a single platform, and a 2023 collaboration with AliveCor, separately indexed here, brought that consumer layer in by integrating the KardiaPro platform to capture and triage data from six lead and single lead consumer devices. Following one patient from a consumer wearable through to an implanted device on one platform is a genuine coverage claim. The billing capability is unusually developed and is stated with more specificity than most vendors offer about anything. Every remote monitoring procedure code is handled automatically, 31 day and 91 day billing cycle tracking is built into the workflow, missed charge recovery runs continuously, code updates are maintained by the vendor, and billing data synchronises bidirectionally with Epic, Oracle Health and athenahealth. Reported outcomes include 98 percent of manual billing entry eliminated and 75 percent average billing capture within 90 days of go live. In June 2026 the company achieved ISO/IEC 27001:2022 certification from a named accredited certification body, publishing the certificate number, and argued publicly that this goes beyond the health privacy statute compliance and service organisation control attestations its named competitors rely on. That is the most substantive security credential held by any vendor built in this session. Evidence includes work presented at HRS 2026 reporting a 61 percent reduction in alert burden, with a named academic cardiologist presenting, and a published case study describing electronic health record integration at a health system and clinician training taking around 15 minutes. Founded in 2015 and based in Clearwater, Florida, led by chief executive Tripp Higgins. One thing a reader should weigh. A competitor's published comparison characterises the platform as built for one manufacturer's devices and describes limitations in multi manufacturer populations, which conflicts with the company's own all device types claim. That is an interested source and the discrepancy is recorded rather than resolved.

Gestalt occupies the layer between the scanner and the algorithm, and it is the only record in this lane that hosts other vendors' models rather than only selling its own. PathFlow is an image management system and digital pathology platform that centralises whole slide images, patient and case information, and artificial intelligence outputs in one workspace, and the positioning is vendor neutral by design: it supports multiple artificial intelligence tools simultaneously so an organisation can evaluate, adopt and change its model strategy without changing platforms. That is a genuine architectural stance rather than marketing. Partnerships have brought outside algorithms onto the platform, including a French vendor's tumour biomarker models for skin tissue and an Indian vendor's quality control models, and the company has an established relationship with one of the largest computational pathology vendors, which is separately indexed here. A platform whose commercial interest lies in hosting competitors' models is a different proposition from the analysis vendors that surround it in this category. The most distinctive product on the record follows from that position. The PathFlow AI Algorithm Evaluator, launched in 2024 and described as patent pending, lets pathologists and researchers assess and compare the performance of artificial intelligence algorithms inside the platform, securely and against their own material. In an index whose recurring finding is that vendors publish no performance data, a tool built so customers can generate their own is worth noting. The company's own models sit mostly upstream of diagnosis. AIRE, the artificial intelligence requisition engine, reads pathology requisition forms including handwritten ones and, in the company's description, insurance cards photographed upside down, validates patient information against the existing database, flags discrepancies for correction and auto accessions cases above a customer set confidence threshold of up to 95 percent, with accessioning time reduced by up to 80 percent. The company states it trains against each new form format and improves over time. Around the platform sit PathCloud for web based image sharing without heavy infrastructure, an education and proficiency testing module used for credentialing, and an information technology services business. Founded in 2017 in Spokane, Washington, with a Series A of $7.5M announced in 2025. Leadership includes president and chief strategy officer Lisa-Jean Clifford, who sits on the governing council of the pathology informatics professional association, and a chief medical officer. The company states eight granted United States patents, two CE marked in vitro diagnostic certifications, compliance to the United States health privacy statute and service organisation control 2, and integrations with Epic, Cerner and other laboratory and record systems. Customers named publicly are mid sized rather than marquee, including a private laboratory in Oklahoma and a veterinary diagnostic laboratory at Purdue University. One thing a reader should weigh. The company describes its artificial intelligence team winning first place in two global competitions, and competition performance is a real but narrow signal that does not establish clinical performance in a laboratory.

Intiveo is a patient engagement platform built specifically for dental and oral surgery practices, and it enters this index alongside Overjet, Pearl and DayDream, which cover dental imaging and revenue cycle. Where those three apply models to radiographs and claims, Intiveo works on the communication layer: two way messaging, recall reminders, appointment confirmations, waitlist management, referrals, chat, surveys, reputation management and integrated voice. The scale is real within its niche. More than 3,000 dental practices across North America, the platform used in 85 percent of dental schools in North America, and a customer base spanning solo practices, multi location groups and dental service organisations. Integrations include practice management systems, with an open source dental system named specifically, and voice built on a commercial cloud communications provider rather than in house. The artificial intelligence is very new and deliberately narrow. Veo, announced 25 June 2026, is described as a growing network of capabilities with two shipping at launch. Suggestions recommends chat templates matching a patient conversation during business hours, with staff free to send, customise or dismiss the suggestion. Responses lets a practice configure automatic replies to common inquiries outside business hours, covering new patient intake questions, office location and parking. Both are logistics and messaging rather than anything clinical, and the company frames the whole programme around control, transparency and configurability, with its chief executive explicitly acknowledging that practices are hesitant and are not looking for technology that removes the human element. The most interesting thing on this record is not the product. In July 2026 the company published a benchmark study drawn from communication and engagement data across more than 2,500 practices between March 2025 and February 2026, segmented by practice size, and the figures are specific enough to be useful to competitors as well as customers: confirmation rates steady at 77 percent industrywide with text driving about two thirds of confirmations, voice growing from 2 percent of channel mix in 2025 to more than 7 percent in 2026, referral conversion to completed treatment at 16.1 percent for solo practices against 23.7 percent for multi location and 25.5 percent for enterprise groups, and practices using the waitlist feature recovering an average of 2,773 appointments a month. Publishing operational benchmarks at that granularity, including numbers that make small practices look worse than large ones, is rare in this index. Founded and headquartered in Vancouver, British Columbia, led by chief executive and co founder Josh DeVries. The company states successful completion of a service organisation control type 2 audit. Two things a reader should weigh. Veo is two months old at the time of this assessment and neither capability has any published performance figure. And the platform's own benchmark report is drawn from its customer base, so it describes the behaviour of practices using this software rather than the market as a whole.

Yosi Health is Clearwave's opposite number and the pair are worth reading together. Both automate the front desk for specialty and ambulatory practices. Clearwave grew from a waiting room kiosk and still deploys hardware; Yosi was built pre arrival and mobile first, on the premise that the registration should be finished before the patient walks in. The company claims to have been the first remote pre arrival patient intake software. The product covers self scheduling from a practice website, pre arrival digital intake, automatic check in, real time eligibility and benefits checks, pre and post visit payment collection, two way texting, surveys and reputation management, and telehealth. Check in runs through tablet kiosks, quick response codes or location detection on the patient's phone, without front desk intervention. The company reports 84 to 85 percent of patients fully pre registering before arrival. Two design decisions distinguish it from competitors and both address the same practical objection. Practices are not required to change their existing forms: the platform maps patient answers onto whatever forms a practice already uses, delivers discrete data into the record system and also produces a completed, signed and dated document packet. And intake questionnaires carry autoscoring, configured by appointment type, patient category, provider and specialty, so a screener produces a score rather than free text a clinician must read and total. The artificial intelligence is narrow and is the basis for enrolment. Voice automation handles routine scheduling and, in the company's own description, triage, providing an always on layer that reduces hold times and routes urgent calls appropriately without replacing the human touch. That is a modest claim, honestly bounded, and it is the strongest model claim on the record. Intake autofill and form mapping are the other candidates and are more plausibly deterministic. The security posture is the most complete of any small vendor assessed in this session and stands in direct contrast to Clearwave, which publishes none. Yosi states service organisation control type 1 and type 2 certification, HITRUST common security framework certification, payment card industry compliance, status as an advanced technology partner in a major cloud provider's independent software vendor programme, and a documented 99.95 percent uptime figure. For a company of this size holding all four credentials is a deliberate and expensive choice. Founded in 2014 in New York by Hari Prasad, after an experience being handed a clipboard at an urgent care with a dislocated shoulder, with the founding team described as physicians and healthcare professionals. Seed funded, with Dreamit named as an investor. Record system integrations are named across Epic, Oracle Health, Allscripts, athenahealth, AdvancedMD and Elation, with real time two way data transfer described, and the platform joined the ModMed specialty marketplace in October 2025. Two things a reader should weigh. The company is small and seed stage against competitors that have raised tens or hundreds of millions, so buyers should weigh continuity accordingly. And the operational figures throughout, including pre registration rates and uptime, are self reported with no method stated.

Clearwave occupies the point in the patient journey nobody else in this index owns end to end: the front desk. Scheduling, eligibility verification, pre registration, check in, clinical intake and payment collection, sold predominantly to specialty practices and multi site groups rather than to academic health systems. The company began as a check in kiosk roughly a decade ago and the physical heritage still shows in how the product is deployed, across kiosks, tablets, mobile devices and pre visit links, with passwordless patient led registration. That kiosk lineage is the reason the operational figures are unusually specific and unusually good: 99 percent patient adoption of registration, check in times down 90 percent, collection rates of 96 percent during check in, point of service collections up between 85 and 154 percent, and eligibility checks running across more than 900 payers. Those numbers come from a product that has been iterated against real waiting rooms for years rather than from a recent launch. On 12 August 2026 the company repositioned the whole platform around what it calls an agentic workforce, naming eight agents: voice answering inbound calls and booking, confirming, cancelling and rescheduling; scheduling filling the calendar across phone, online, search and call centre; eligibility running real time checks; clinical intake collecting clinical data before arrival; pre registration capturing demographics and consents; check in completing in under two minutes; payments collecting copay, past due balances and surcharges; and communications. The stated volumes are substantial, with the voice agent handling more than 50,000 patient calls a month at roughly 90 seconds each, and the check in and pre registration agents described as automating 150 million patient visits a year. The positioning claim is worth quoting in substance because it is the argument the whole record turns on. The company frames the platform as automating the work rather than as software that helps staff work faster, and pitches one platform replacing as many as ten point solutions. That is a strong claim about autonomy and it is made two weeks before this assessment, which matters for how much weight the evidence can carry. Based in Atlanta, Georgia. Practice management and record system integrations are described as deep, with NextGen named specifically and the integration marketed jointly. Two things a reader should weigh. The registration and eligibility evidence is mature and specific; the agentic evidence is a launch announcement carrying figures of 63 percent faster than human agents, an 89 percent drop in staff workloads and 86 percent less training time, none of which has a stated method, baseline or comparison group. And the product sits at the intersection of clinical intake and payment collection, which means the same interface that asks a patient about their symptoms also asks them for money, and nothing published addresses how those two functions are kept separate in the patient's experience.

symplr is the largest company assessed in this part of the index and the one furthest from the bedside. It sells healthcare operations software: credentialing and provider data management, workforce scheduling and timekeeping, contract lifecycle and spend management, vendor access control, and compliance, quality and safety. The framing the company and its investors use is governance, risk and compliance for healthcare, and that is an accurate description of what a buyer is purchasing. It is enrolled rather than screened because it is healthcare exclusive and because the models are real and specific. It sits at the outer boundary of this index by subject matter, not by whether it ships intelligence. Three artificial intelligence capabilities are concrete enough to assess. Smart Square, the workforce product acquired from AMN Healthcare in 2025 for roughly $75M and now merging with the existing workforce product, applies predictive analytics and real time record system driven data to nurse and staff scheduling, aligning staffing to forecast patient demand, and has been recognised by an independent healthcare research firm as a leader specifically for that predictive capability. Contract lifecycle management gained conversational access to contract data plus assisted review and redlining that flags risk and suggests edits. Vendor access gained automated credential verification through a smart badge that replaces manual kiosk check in with real time compliance tracking. Provider data management, the product that competes most directly with Kyruus Health, maintains directory accuracy and network management for health plans against their regulatory obligations. Scale is the defining fact and it is very large. Deployments in nine of ten United States hospitals, more than 400 health plans, and over 6,000 customer locations. The platform runs on Amazon Web Services infrastructure, launched as a unified operations platform in February 2025 after years of the portfolio being separate products. The company was founded in 2006 in Houston, Texas, and is privately held under Clearlake Capital and Charlesbank Capital Partners with SkyKnight Capital, following an ownership history that includes Francisco Partners and earlier sponsors. It has completed at least nine acquisitions since 2018, which is what produced the breadth, and is led by chief executive BJ Schaknowski. Two things a reader should weigh. This is a buy and build platform, so the products carry different heritages and nothing published describes how far the underlying technology has been unified beyond the shared platform layer; a buyer should establish which module carries which lineage. And the artificial intelligence sits in operations rather than in care, so a hospital evaluating this is assessing whether models should influence who is scheduled to work and which contracts get flagged, not whether models should influence a patient's treatment. Those are different questions and the second is not asked here.

Kyruus Health is the incumbent in patient access and the only vendor in this part of the index that sells the same platform to both sides of the market. Where Loyal Health serves provider organisations and RadiantGraph serves payers, Kyruus does both, which is the direct result of an acquisition strategy rather than a product decision. The foundation is provider data rather than conversation. The platform maintains a single authoritative source of provider information across a network, ingesting, curating and cleansing records from multiple systems, then distributing that data outward to health system websites, scheduling systems, search engines, listings, record systems and payer directories. Everything else depends on it: a matching engine cannot route a patient to the right clinician if the underlying data on specialty, insurance, language, location and availability is wrong, and provider directory inaccuracy is both a chronic operational problem and a regulated one for health plans. The commercial products sit on top as named modules covering listings management, provider search, patient self scheduling with direct record system integration, and digital intake, payment and check in, alongside published application programming interfaces for search, availability and scheduling. The artificial intelligence claims are concentrated in three places and are more specific than most in this category. Data quality monitoring identifies inaccurate or outdated provider records across a directory. Patient to provider matching connects a person to an appropriate clinician on specialty, location, insurance, language and availability rather than on a keyword. And conversational search, launched for health plans, replaces filter and jargon driven directory navigation with natural language, with the company's own chief product officer framing complex filters and clinical jargon as the barrier being removed. Predictive access analytics identifying where access barriers exist across a network are also described. Scale is the strongest fact on the record and predates the current artificial intelligence positioning by years. Public statements have described 600 hospitals and more than a quarter of a million providers, 70 health systems and 100 health plan brands after the payer acquisition, and more than 80 million health plan members reached through the acquired payer business. Named health system customers include Intermountain Health. Record system integrations are named for Epic, Oracle Health, MEDITECH and athenahealth. Founded in 2010 in Boston by Graham Gardner and Julie Yoo, with roughly $196M raised across ten rounds from Highland Capital Partners, Venrock, Francisco Partners, Providence Ventures, Cambia Health Solutions, UPMC Enterprises and Salesforce Ventures. The company acquired HealthSparq from Cambia in 2021, opening the health plan business, and Epion Health in 2022, adding digital patient engagement and intake. Kyruus Health was itself acquired by RevSpring in September 2025, and the brand continues to trade under its own name, which is why it is enrolled. Two things a reader should weigh. The platform is now three companies joined together and nothing published describes how far the underlying technology has actually been unified, so a buyer should establish which module carries which heritage. And the artificial intelligence is real but sits on the data layer rather than in front of the patient, so this is a matching and directory business with models inside it rather than a conversational product.

Loyal Health is enrolled under the acquired vendor test rather than in spite of it. Clarify Health completed its acquisition of Loyal Health Holdings on 4 June 2026, and the brand demonstrably survives: the acquirer's own announcement markets the Care Activation Platform under the Loyal name, loyalhealth.com continues to operate as a distinct commercial surface, and health system partnerships continue to be signed under the Loyal name. A brand still sold under its own name is admitted, and the acquisition is documented here so a buyer searching for Loyal finds out what happened to it. The company sits further toward marketing than anything else in this part of the index, and that is the honest framing rather than a criticism. Where Keona Health and Clearstep are built around clinical triage protocols, Loyal is built around getting a patient to choose a health system, find the right doctor and book. The platform covers provider data management across more than 80,000 provider and location profiles, intelligent care search, real time scheduling, online listings, reputation and reviews management, a healthcare customer relationship management layer, and conversational chat. The centre of gravity is patient acquisition and retention, and the clinical work the chat does is triage in service of routing rather than triage as the product. The conversational product has the longest history. Guide, launched as a hybrid live and artificial intelligence chat solution, was described at the time as backed by a custom built neural network, and joined the Epic App Orchard in 2018 to book appointments directly into underlying scheduling systems from inside a chat conversation. That is early for direct scheduling from chat and it remains the capability that distinguishes this from a website widget. During the pandemic the same chat carried a risk assessment tool used to direct patients toward telehealth or in person care, which is the closest this platform comes to acuity work. Scale is the strongest fact on the record and it is corroborated from the customer side. Every one of LifePoint Health's more than 80 hospitals uses the chat and live chat solution for scheduling and triage functions under a five year partnership, and Northwestern Medicine and UCLA Health have been named among more than 30 hospital systems. The acquirer states the platform powers millions of patient searches and real time scheduling transactions annually. Founded in 2015 in Atlanta by a team led by Chad Mallory, with Brian Gresh as president through the growth years. A $12.5M Series A led by Concord Health Partners closed in 2020, followed by a Series B. The company publishes a service organisation control type 2 compliance claim and a health privacy statute compliance statement on its own site, which is more than most records in this category offer. Two things a reader should weigh. The acquisition is recent enough that how much of this survives as a distinct product is genuinely unsettled, and the acquirer's framing points toward integration into a combined intelligence and activation platform rather than indefinite independence. And the artificial intelligence description has not visibly moved since the custom built neural network language of the late 2010s, so what runs the conversation today is not established by anything published.

Cedar Gate Technologies is the vendor in this lane that actually moves the money. Most value based care platforms measure performance under a risk contract and hand the result to someone else to act on. Cedar Gate does that and then adjudicates the payment, running bundled and capitated arrangements end to end on software rather than on spreadsheets and manual reconciliation. The platform has four layers on one data foundation. Enterprise data management ingests claims, clinical, eligibility and benefits data into a single lake, cleanses and normalises it and stitches records to members. Analytics sits above it, covering value based care performance, benefits analytics for self funded employers and benchmarking against an anonymised database described as covering 12 million member lives. Care management supplies workflow and engagement. Payment technology adjudicates, with a bundles engine acquired in 2018 that automatically converts fee for service claims into a single bundled claim and manages the payment between payer and provider, and a separate capitation engine that administers capitated agreements and eligibility. Most of that estate was bought rather than built. The company was founded in 2014 by David Snow, previously chief executive of a large pharmacy benefit manager, with backing from a private equity firm, and launched its own analytics tool in 2016. Global Healthcare Alliance followed in 2018, bringing the bundled payment engine and a lineage in bundled payments the company now describes as spanning more than forty years, then Citra Health Solutions, Deerwalk and Enli Health Intelligence in 2020. Ownership changed in late 2025, when IQVIA acquired the company in a transaction reported at around 750 million dollars. The brand continues to be sold under its own name as an IQVIA business and product launches have continued since, including a prospective bundled payment suite in March 2026 supporting the mandated Transforming Episode Accountability Model, so the change of owner does not alter how this record reads. Buyers span health plans, provider organisations, self funded employers, third party administrators and advisers, across commercial, Medicare and Medicaid lines and across primary care attribution, shared savings, bundles and capitation. Named customers include Kairos Health Arizona, MedBen and Baptist Memorial Health Care. Roughly 1,000 employees across offices in Greenwich, Burlington and Houston, a large remote workforce and a team in Nepal. Two things a reader should weigh. A bundled payment case study presented at an industry summit in 2026 reports 97 percent patient satisfaction, 91 percent avoided inpatient hospital care, a 60 percent reduction in total cost of care and a 50 percent reduction in surgical rates, and figures of that magnitude carry no denominator, period, comparison group or stated method. And a dedicated pass located no security certification of any kind and no pricing of any kind.

Luminai automates the administrative work health systems still do by hand, end to end rather than task by task. Healthcare trained models structure unstructured documents and fragmented data, workflow automation carries the resulting actions across disconnected systems, and human in the loop validation gates the steps that need a person. Named workflows span referral intake, provider inbox automation, patient registration, order and referral processing, pharmacy renewals, payor contract management, denial appeals and underpayment recovery, grouped commercially under patient access, revenue cycle and compliance. The integration approach is the unusual part and comes from the company's earlier life as a cross industry automation platform. Rather than requiring an interface build, the software operates the systems a team already uses, which means it can reach applications that expose no usable programming interface. That is how the platform gets into the corners of health system operations where the data lives in a portal nobody can integrate with, and it is also why standards based interoperability is not the story here. The security and deployment posture is the strongest element of the record and is unusual for a company at this stage. Three deployment models are offered: on premise, inside the customer's own virtual private cloud, or vendor managed. Alongside that the company describes encrypted data, isolated execution and, notably, customer owned credentials, meaning the automation acts using the customer's own system credentials rather than the vendor holding them. Alignment is claimed against United States health privacy law, service organisation controls and European data protection law. A 38 million dollar Series B closed in April 2026, led by Peak XV Partners with new investor Define Ventures and continued backing from General Catalyst and Y Combinator, bringing total capital to 60 million. The team draws from Palantir, Google, Coinbase and Brex on the technology side and from Epic and Banner Health on the operator side. Based in San Francisco. Two cautions. The company states it is trusted by large health systems and names none of them publicly, so no customer, deployment scale or outcome could be verified. And several third party directory pages carry precise sounding figures for return on investment and time to value that trace to no primary source and bear the marks of generated content; none of them informed this record.

Aidin runs the discharge referral, from the moment a case manager decides a patient needs post acute care to the moment a facility accepts them. Referrals, records, authorizations and care partner relationships sit in one platform, and the document layer absorbs the formats this work still arrives in, pulling material from fax, email and the company's own print path and classifying it against the right patient and request. Task flags surface incomplete flows, at risk cases and overdue assignments, and a secure messaging layer replaces the phone calls. The distinctive design choice is the open market. Rather than routing patients to a hospital's existing preferred partners, Aidin presents post acute providers with objective quality, satisfaction and outcome data so the patient can choose, and it operates a national directory of care partners on the other side. Post acute providers get free access to receive referrals, with paid tiers named as Verified, Community and Enterprise unlocking record system integration, custom reporting and team workflow. That two sided structure means the platform's reach on the receiving side is a commercial asset in its own right. Customers named in company case material include UCLA Health, five hospitals of the Ohio State University Medical Center, St. Luke's, Elmhurst Edward Hospital and Western Maryland Health System, with stated objectives around average length of stay, inpatient bed capacity and readmission reduction. Regulatory posture is more directly addressed than in most records here. The platform is built against the federal post acute discharge list requirements, which oblige hospitals to give patients quality data and a genuine choice of provider, and the open market model is a direct implementation of that obligation rather than a feature bolted beside it. Led by chief executive Russ Graney. One thing a reader should hold. The company describes an artificial intelligence powered platform, and the identifiable machine learning in it is document intake classification and provider quality analytics. Around that sits a directory, a workflow tool, an authorization tracker and a messaging layer, none of which is inference. No model is described, no performance figure is published for any component, and a dedicated pass located no security page, no external attestation and no published price. This record grades the disclosure available rather than the positioning.

Operating room block time optimisation built around a machine learning prediction. The platform, ARDEN, forecasts which allocated surgical block time is likely to go unused and reallocates it according to the facility's financial objectives, clinical priorities and individual surgeon preferences, making recovered time available to surgeons looking for capacity. Modules are separately installable. Buyers are hospitals and ambulatory surgery centres. Founded by Michael Burke, chief executive, and Keyton Weissinger. Based in the Atlanta area, with sources giving both Atlanta and Alpharetta, and disagreeing on founding year between 2019 and 2021. The design combines machine learning with behavioural economics, which is an unusual pairing and the more interesting half of the proposition. Predicting an unused block is a modelling problem; persuading a surgeon to release time they have been allocated and may want to keep is an incentive problem, and the company treats both as part of the product rather than assuming the prediction is sufficient. This record sits deliberately alongside the two perioperative vendors built immediately before it, because the three together show the range in one narrow lane. LiveData has thirty five years of workflow software and a conversational query layer three months old, so its intelligence is peripheral. Apella raised 101 million dollars to put computer vision in the room, so its intelligence is the entire product. Copient is a six person company whose intelligence is also the entire product. Scale and centrality are independent, and a buyer comparing the lane should see that. Scale and viability are the material risk on this record. Funding is 3.2 million dollars raised in a single Series A in January 2022 led by Atlanta Ventures with First Trust Capital Partners and Atlanta Seed Company, with no subsequent round located more than four years later. Headcount was reported at six in July 2024 with no more recent figure found. A hospital signing a multi year agreement for a system that reallocates surgeon block time should weigh continuity alongside capability. Disclosure is minimal. A dedicated pass located no named customer, no outcome figure, no security certification, no trust page, no integration specification and no pricing information. Published material consists of product description and a marketing blog. The grades below reflect that and are a finding about what a buyer can verify rather than a judgement about whether the model works.

Perioperative workflow and surgical capacity software, independent and operating from Cambridge, Massachusetts since 1991. Annual revenue is estimated by a third party at roughly 7 million dollars, making this one of the smallest records in the index by revenue and one of the oldest by tenure. The product is the PeriOp Manager suite, a set of coordinated modules rather than a single application: PeriOp Planner for surgical scheduling, Patient Flow for check in and check out, PreOp Board, OR-Dashboard with Active Time Out, OR-Schedule Board, Family Waiting Board, Procedure Suite Manager, PeriOp Mobile Messenger and PeriOp Manager Analytics, with LiveData Insights as the analytics cloud above them. OR-Dashboard blends data from the electronic record, anaesthesia systems and physiological monitoring devices into a live view of the case, and staff record milestones and complete safety checklists through a wireless handheld device. That capture method is the reason this record is worth reading alongside Apella. Both companies produce the same underlying dataset, surgical case events timed to the minute, and they obtain it in opposite ways: one by having a member of staff press a button, the other by computer vision inferring the event autonomously. The trade is explicit rather than theoretical. The manual route costs staff attention and produces a record a human authored; the automated route costs nothing at the point of care and produces a record no human reviewed. A buyer choosing between them is choosing which of those they prefer, and the index should let them see it. The artificial intelligence is new and narrow. LiveData Insights AI Advisor launched 21 May 2026 as a conversational layer allowing leaders to ask plain language questions about block utilisation, case volume, late starts and turnover time, with answers stated to be grounded in the health system's own data rather than generic benchmarks. It works with any electronic record, requires no proprietary data pipeline, and runs inside the existing analytics cloud with role based access. A chief product officer was appointed in 2026 specifically to accelerate artificial intelligence work, which places the company at the beginning of that transition rather than partway through it. One credential stands out and has nothing to do with artificial intelligence. OR-Dashboard with Active Time Out has been designated a Leading Practice by the hospital accreditation body, which is a patient safety recognition from the organisation that inspects hospitals rather than a marketing award, and is the only credential of that character encountered in this sweep. The company was also named among 25 Forbes Small Giants in 2019. Disclosure limitation: a dedicated pass located no security certification, trust page, pricing information or named customer.

Ambient artificial intelligence and computer vision for the operating room. Sensors installed in the room observe surgical activity, machine learning models automatically identify up to fourteen distinct case events, and the resulting structured data is written autonomously back into the electronic record and fed into scheduling, utilisation and turnover analytics. Founded 2020 by David Schummers, chief executive, and Cameron Marlow, chief technology officer. Headquartered in San Francisco, with some sources giving Oakland. The rationale is concentration of value rather than breadth. The company states that up to 60 percent of a health system's revenue and 40 percent of its costs sit in the operating room, which makes perioperative capacity the highest leverage target in hospital operations. A later product, Horizon, forecasts case duration and utilisation to optimise scheduling before the day begins rather than reacting during it. Funding totals 101 million dollars: a 21 million dollar Series A in December 2021 led by Casdin Capital, and an 80 million dollar Series B of equity and venture debt announced 8 January 2026 led by HighlandX, with returning investors Vensana Capital, Casdin Capital, PFM Health Sciences, Upside Partnership and Operator Partners, and new investors K2 HealthVentures, OpAmp Capital and Houston Methodist. The president of the Johns Hopkins Health System joined the board. The flagship deployment is Houston Methodist, a nine hospital system that ran an initial 36 room pilot and has since scaled to more than 200 operating rooms enterprise wide, with its executive vice president and chief innovation officer quoted on the result. That reference carries a disclosed conflict this record records plainly: Houston Methodist is also an investor in the Series B, and the quoted executive appears among the company's individual investors. The evidence is real and the commercial relationship runs both ways. The headline outcome claim is an average 5 percent increase in surgical volume across customers, vendor stated with no methodology or study attached. Two characteristics distinguish this record from everything else in the lane and drive several grades. The system writes machine generated observations autonomously into the legal medical record, which is a different act from advising a human. And the data it collects is continuous video of surgical procedures, capturing patients under anaesthesia and the staff around them. Neither is addressed in any published material located, and both are recorded on the relevant axes. Disclosure limitation: a dedicated pass located no security certification, trust page, privacy posture, integration specification or pricing information. The trust axes are graded conservatively on that basis and should be revisited.

End to end cloud platform for home and community based care, spanning needs assessment, care planning, clinical documentation, scheduling and route optimisation, visit verification, billing, family portals, remote patient monitoring, telehealth and mobile care worker applications. Founded 2014 by Adrian Schauer, who won a national entrepreneur award in 2025. Roughly 608 staff as of February 2026. Sources disagree on headquarters, giving Toronto and Montreal, with a United States entity registered in Boston. Market coverage is unusually specific and genuinely international. The platform is sold across Canada, the United States and Australia, into private duty nursing and non skilled care, Medicaid, community support services, therapy, patient support programmes, clinical pharmacy, hospice, home infusion, and Australian aged care including consumer directed care and the national disability scheme. That last is a country specific programme rather than a generic claim to international availability. The artificial intelligence sits on top of the platform rather than being it. A dedicated research group develops the capability, which covers predictive analytics flagging clients at risk before escalation, clinical documentation extraction, travel time reduction, an employee retention dashboard, and back office automation. Two named products carry it: Layla, an assistant launched in Canada in June 2025, and AlayaFlow, agentic workflow automation launched in October 2025. The company claims agencies reclaim 80 percent of time and costs through the newer automation, a figure published in March 2026 and unsupported by any study located. Trust posture is stronger than most records in this index. A trust centre exists as a named destination, the platform is stated to meet four named privacy frameworks across two countries and to pass regular controls audits at the more demanding report type, with the original certification audited by a named accounting firm in 2020. Infrastructure runs on a named public cloud with data sovereignty cited as a design consideration across the three markets. The finding worth flagging is on governance. The company publicly references its signatory status under a national voluntary code of conduct for advanced generative artificial intelligence systems, which is the first verifiable artificial intelligence governance credential recorded anywhere in this index. It is a commitment framework rather than published evidence, and it is more than any competitor offers. No pricing is published by the vendor. Third party software directories estimate entry cost around 1,000 dollars per month scaling with practitioner count, modules, integrations and training, and one explicitly rates the company's pricing transparency as low. Those are estimates rather than disclosure and are recorded as such. Named customers include CBI Home Health, which renewed nationally in June 2025, and a group of 33 community support agencies modernised in August 2025. Financing includes a 50 million dollar growth capital facility from a Canadian bank in February 2026.

Patient flow and capacity management for hospitals and health systems, and the incumbent against which LeanTaaS and Qventus are usually evaluated. Headquartered in Pittsburgh, operating for more than three decades, with a reported 369 employees and a stated global footprint of more than 200,000 managed beds representing millions of patient stays annually across North America and Europe. The product is the Operations IQ Platform, rebranded in October 2024 as the company completed a move from installed software to a hosted model. Capacity IQ handles bed management, discharge efficiency, turnover and emergency department boarding. Workflow IQ covers perioperative settings. Transfer IQ manages patient transfers within and between facilities. Referral IQ connects owned and affiliated referring providers. Data IQ delivers enterprise analytics. Underneath sits three decades of workflow automation, transport dispatch and real time location technology, which the company combined with patient flow software to create a real time capacity platform. The artificial intelligence is recent and is one module among several. Decision IQ launched on 20 November 2025 as what the company describes as the first artificial intelligence driven solution for managing patient flow at scale, replacing retrospective reporting with forward looking system wide visibility so teams can anticipate throughput constraints before they bite. University of Louisville Health is the named early adopter, expanding a longstanding transfer operations relationship. The company's own framing pairs more than thirty years of operational expertise with advanced artificial intelligence, which is an accurate description of the balance and is the reason the centrality grade on this record sits low. Membership was decided on the centrality grade rather than the reject filter, following the Aetion precedent. This is a healthcare only technology company rather than a horizontal vendor and it is not a services business, so neither of those filters applies. What is true is that most of the platform would function without a model, and that is recorded on the axis built for it rather than treated as disqualifying. Ownership note requiring verification before quotation: one vendor database records the company as acquired by an entity named Aionex, and no confirming source was located. The brand plainly survives under its own name regardless, carrying its own domain, its own current copyright, its own product line and a November 2025 product launch in its own name, so the acquired vendor ruling is satisfied either way. The gap across this record is disclosure rather than capability. A dedicated pass located no security certification, trust page, privacy posture, pricing information, integration specification or published outcome figure for the artificial intelligence product. For a vendor of this tenure and installed base, that is a striking amount of nothing.

Patient access and revenue cycle automation built around an agent platform the company calls a Healthcare Revenue Operating System. Founded 2012 and headquartered in Cupertino, California, originally as a radiology prior authorisation business, now spanning financial clearance, prior authorisation, document capture, coding, denials and accounts receivable. Backed by KKR and Norwest with roughly 194 million dollars raised, serving a reported 900 or more provider organisations, and having acquired the healthcare revenue cycle business of i3 Verticals. The architecture is a three tier agent model stated plainly. Automation agents handle high volume repetitive work such as eligibility verification, claim status tracking and payment posting. Artificial intelligence agents handle work requiring cognitive reasoning and action, such as classifying and extracting patient detail from referrals or predicting denial risk before submission. Human agent specialists supplied by the company step in for complex denials, payer escalations, credential verification and prior authorisation exceptions. Agent suites sit on top: Patient Access Plus, Document Capture Plus and a revenue cycle suite, available standalone or integrated. Membership was decided on the services filter and survived it. The company's own framing is technology led outcomes delivered through agentic solutions, outsourced operations and consulting, which puts technology rather than expertise in the load bearing position and inverts the Cotiviti formulation. Standalone solutions are offered without a services engagement. And in April 2026 its in scope revenue cycle and patient access platforms and supporting environments attained HITRUST Implemented one year certification under framework version 11.5.1: a certification is scoped to a product and an environment, which is evidence the platform is a discrete licensable thing rather than a wrapper on a service. The company does supply human labour as a named component, which is why the artificial intelligence centrality grade sits below the pure engines in this index. Infrastructure is named more openly than most. Amazon Web Services is the cloud foundation, with a managed foundation model service used for summarisation and workflow understanding, alongside named data stores, private network segmentation, encryption at rest and in transit and permission gated file access. One relationship connects this record to the coding lane. In August 2025 Infinx made a strategic investment in Maverick Medical AI to bring real time autonomous coding into its offering, which means part of the coding capability may originate outside the company. That relationship is documented from the other side in the Maverick record. The gap across this record is measurement. No accuracy figure, automation rate, service commitment or price is published anywhere, and the only quantified customer outcome located is a single named practice reporting case handling time falling from roughly three and a half minutes to under one.

Indexed as a product rather than as a company, under the index by product not company rule. Optum itself is screened out at company level on breadth, following the Hologic precedent; this record covers the qualifying product line only. Optum Integrity One is an autonomous first platform for the middle revenue cycle, launched 7 May 2025 by Optum Insight and powered by the company's patented Clinical Language Intelligence technology. It analyses the patient record as documentation is created, applies coding logic in real time, and completes routine encounters automatically, consolidating clinical documentation review, code assignment and charge capture into one interface. The stated design offers both fully autonomous and partially autonomous coding, escalating to a human expert when clinical signals indicate complexity: the company's worked example has many emergency department cases coded autonomously while a chest pain admission surfaces a documentation opportunity on the likely presence, type and acuity of heart failure, routed to the documentation integrity team for a provider query. Part of the stated value is consolidation rather than intelligence. Published benefits include reduced need for multiple vendors and lower total cost of ownership alongside the automation itself, which distinguishes this from the pure coding engines elsewhere in the lane. Published outcomes are anonymous. A pilot is reported at over 20 percent coding productivity improvement, and one unnamed large health system at 180 percent documentation integrity financial impact with a 50 percent rise in inpatient coding productivity. No accuracy figure, automation rate or named Integrity One customer was located. Named references on the Optum site attach to the older assistive coding products rather than to this platform. Optum was named a leader in a 2026 analyst assessment of revenue cycle platforms, which is a company level ranking. Two structural facts belong on the record because no competitor carries them. The vendor is a subsidiary of the largest health insurer in the United States, so a platform that surfaces documentation opportunities to increase captured clinical acuity is sold to providers by the corporate family that also pays their claims and whose risk adjustment coding practices have drawn federal scrutiny. And Change Healthcare, an Optum company, suffered a ransomware incident in February 2024 subsequently reported as the largest breach of protected health information in United States history. Neither is addressed in the product's published material, and a buyer evaluating protected data handling by an Optum entity will weigh both. Disclosure limitation on this record: a dedicated pass located no security, compliance, integration, residency or pricing material tied to this product. An organisation of this scale certainly maintains extensive compliance infrastructure; none of it was found surfaced at the product level, and company level material was not exhaustively searched. The trust and security axes are graded conservatively for that reason and should be revisited.

Inpatient medical coding and pre bill auditing software built on custom clinical artificial intelligence and natural language processing. Two products sit on one platform: Semantic Coder reviews charts before they are coded and suggests the relevant diagnosis and procedure codes with a full evidence trail back to the documentation, and Semantic Auditor performs pre bill review of coded data to validate, identify and further specify codes against the clinical record. Founded 2019 in Toronto by Hassan W Bhatti and Nicola Sahar, a physician who serves as president. The positioning is assistive rather than autonomous. The stated aim is to reduce time to code and to let coding and auditing teams focus on high value work, with every suggestion linked directly to the documentation in one interface so that a human can confirm it without consulting other sources. The company draws an explicit contrast with computer assisted coding tools it characterises as rules based or expert curated heuristics, arguing that those produce false positives that cost reviewers more time than they save. One coverage fact distinguishes this record from everything else in the index: the company sells into two national coding regimes, offering American hospitals a pre bill inpatient auditing platform and Canadian hospitals a health information management platform that auto suggests codes and reviews all coded data for quality. No other vendor in this lane addresses a coding system outside the United States. Named customers are Hospital for Sick Children and Humber River Hospital in Toronto, and Boston Children's Hospital and Cedars-Sinai in the United States. Acquired by AAPC on 16 November 2023. AAPC is a Utah based credentialing, education and revenue cycle organisation serving a reported 250,000 members, and its chief business development officer stated at announcement that Semantic Health would remain a separate entity for the foreseeable future with autonomy to operate. The brand passes the distinct presence test: own domain, own product names, own platform identity, and a customer roster that has grown since the close to include two major United States systems not present in 2023 coverage. The caution that matters most on this record is not about the product. The public presence appears to have gone largely static since the acquisition. No security page, pricing information, certification, published performance figure, funding update or product announcement was located in a dedicated pass, and the on site performance statistics render without values. Total disclosed funding is roughly 3.3 million dollars raised before the acquisition. A buyer will have to obtain almost everything through direct contact, and the record should be rechecked before it is a year old.

Clinical artificial intelligence for hospital revenue integrity, built around second level review of every patient chart before final billing. The engine ingests the complete clinical record, reported at more than 30,000 data points per chart with no chart prioritisation, and surfaces missing or incorrect diagnoses, uncaptured charges and denial evidence for the customer's clinical documentation and coding teams to validate. Founded 2020 in New York by Michael Gao, chief executive, and Joshua Geleris, both physicians; Gao previously led artificial intelligence work at NewYork-Presbyterian. The positioning is deliberately not autonomy. The company's stated aim is to empower documentation and coding teams rather than replace them, and every finding is validated by a human before it reaches a claim. That is the opposite pole from Fathom and Nym Health, and it is the reason the record grades the way it does: oversight is total by design and no output is submitted by the vendor. The product line spans the revenue cycle in three stages: SmarterAuthorizations and SmarterUtilization before care, SmarterNotes and SmarterPrebill and SmarterCharges around the encounter, and SmarterDenials and SmarterUnderpayments after the claim. SmarterNotes came out of the September 2025 acquisition of Pieces Technologies and combines note generation with concurrent revenue cycle intelligence. Evidence is the strongest part of the record. Named clients include Novant Health, McLaren Health, UCHealth, OHSU, UAMS, Universal Health Services, Franciscan and Baptist Health Arkansas. Case studies are attributed to named executives at named institutions, including a chief financial officer at McLaren reporting more than 11 million dollars in annualised net new revenue against review of 100 percent of clinical data across 100 percent of charts. The company reports a 5 to 1 return, an average of 2 million dollars in net new annual revenue per 10,000 patient discharges, 100 percent client retention and a KLAS client satisfaction score of 98. Models are stated to be trained on more than 21 million real patient encounters. The central claim carries a structural caveat a buyer should hold onto: net new revenue found is a counterfactual, measuring money the organisation asserts it would otherwise have missed, and no independent audit of that counterfactual exists. Funding is 71 million dollars across three rounds, a seed round in 2022 co led by Flare Capital Partners with Floodgate Fund and Bessemer Venture Partners, and a 50 million dollar Series B in May 2024 led by Transformation Capital. In April 2025 New Mountain Capital invested at a reported one billion dollar valuation, and the business now sits inside that firm's Smarter Technologies platform. The brand passes the distinct presence test comfortably: own domain, own logo, own product line, own application and support subdomains, own current copyright, and no parent branding on the property.

Autonomous medical coding platform that pairs large language models with clinical knowledge graphs, reading unstructured charts in clinical context and assigning specialty specific CPT, ICD-10, HCC and HCPCS codes with modifiers and units, without human intervention. Founded in 2020 by Nitesh Shroff, chief executive, and Preeti Bhargava, chief technology officer, both machine learning doctorates. Headquartered in Austin with engineering in Bengaluru. Company press releases during 2026 carry a San Francisco dateline following the opening of a Bay Area office, so the stated headquarters should be rechecked before this record is quoted. The distribution position is the part worth attention. Arintra has been available through the Epic Toolbox since December 2024 and integrates bidirectionally with Epic, Cerner and Athenahealth, writing claims to billing with no manual retyping. That places it in the same Epic distribution lane as Nym Health rather than alongside vendors that sit beside the record system. Outcome claims are vendor stated: five percent or more revenue uplift, twelve percent or more reduction in accounts receivable days, and forty three percent or more fewer denials. The company reported eight times year over year revenue growth for 2025, thirteen enterprise deals in one hundred days, and monthly coding volume up more than fivefold, now covering most ambulatory specialties along with urgent care, the emergency department, inpatient rounding, radiology and pathology. Independent signal is stronger than most early stage entrants in this category. KLAS published an Emerging Company Spotlight on Arintra in 2026, and the company reports a customer performance score of 93 out of 100 against a stated 2026 Best in KLAS software average of 81.1. It holds HITRUST e1 certification obtained April 2026, a lower tier than the i1 certification Fathom holds. Named customers include Mercyhealth and Med First. In April 2026 it added a documentation improvement capability, extending the product past coding into clinical documentation improvement and payer aware denials insight. Funding is roughly 46 million dollars: 21 million dollars Series A in August 2025 led by Peak XV Partners with Endeavor Health Ventures, Y Combinator, Counterpart Ventures, Spider Capital and Ten13 participating, and approximately 25 million dollars Series B announced 24 August 2026 led by Define Ventures with Yale New Haven Ventures and Endeavor Ventures joining.

Autonomous medical coding sold as one member of a named agent lineup rather than as a standalone engine. Amy is the coder; the same platform carries Mark for billing, Adam for accounts receivable, Rachel for appeals and Taylor for analytics. Founded 2022 in San Francisco by Sourabh Agrawal, chief executive, and Shikha Mohanty. Amy reads encounter notes directly from the record system and assigns ICD-10, CPT, HCPCS Level II, evaluation and management levels, modifiers and hierarchical condition categories, with configurable coding grids and payer specific rules. Two design choices distinguish it. Decisions are explainable line by line, with rationale and evidence attached to each assignment, which is the same audit trail argument Nym Health makes. And the platform learns continuously from payer outcomes including denials, reimbursements and underpayments rather than from chart data alone, which is uncommon in this category and carries a governance question the company does not address. Oversight is specified more fully than anywhere else in this lane. A four stage quality process runs model confidence scoring with uncertainty flags, secondary model validation, human review by certified coders, and a live compliance feedback stage tracking claims and corrections in production. The confidence threshold governing when work routes to a human is configurable by the customer rather than fixed by the vendor. Published performance is 97.2 percent coding accuracy, an 85 percent claim automation rate and a 64 percent reduction in overall denials. The company published a parallel coding study across 1,000 emergency department charts comparing its output against expert human coders on the same charts, reporting 97 percent accuracy, turnaround roughly halved and five times more documentation gaps surfaced. That study was designed, run and reported by the vendor. Evidence concentrates in emergency departments and anesthesia. Named customers include Medcor, Homeward, McFarland Clinic, SignatureCare ER and El Mirage ER, alongside anonymised references at a 500 bed hospital, a 400 bed emergency focused hospital and a 150 provider emergency physician group. Integration is claimed across twelve named record and practice management systems, the broadest coverage in the category, though no vendor marketplace listing was located and the company describes custom interfaces built per customer. Data stewardship is the strongest in this lane: customers own their data, it is not sold, shared or repurposed, deletion or export can be requested at any time, and the company states it does not train on customer data without permission, using de identified data or obtained consent. Two cautions for anyone quoting this record. The public material contradicts itself, asserting fully compliant and accurate outputs on the frequently asked questions page against the 97.2 percent figure published elsewhere on the same site, and that page still describes a scribe and a policy reviewer agent that no longer appear in the product navigation. And nothing about pricing is published anywhere. Funding is a single institutional round of undisclosed amount, making this the earliest stage record in the category and the one most likely to need a status recheck within a year.

Autonomous medical coding inside a wider mid revenue cycle platform spanning clinical documentation improvement, coding, pre bill scrubbing, claim submission, accounts receivable follow up and denial appeals. Founded 2023 and headquartered in New York by Dushyant Mishra, chief executive, Jot Sarup Singh, chief technology and product officer, and Abhinay Vyas, chief data officer. Some databases list a Wilmington, Delaware address, which is incorporation rather than operations. The coding engine is RapidCode. RapidAssist is the assisted mode for augmenting existing coders, and RapidRules is a policy engine the company states continuously ingests payer policy updates, denial patterns and regulatory changes. Built on large language models, generating audit ready traceable documentation for the coding team, which is the compliance posture this category has converged on. The differentiating claim is calibration cost. RapidClaims states it customizes pre trained models with roughly 500 sample charts where competitors require 10,000 or more, with models trained across more than 25 specialties. If accurate that materially shortens time to value and lowers the barrier for mid sized organizations, and it is the claim most worth validating against a reference customer. Vendor published figures are 96 to 98 percent accuracy, more than 1,000 charts processed per minute, up to 70 percent reduction in coding cost, 1.7 times coder productivity, denial reduction of up to 27 to 40 percent depending on the source, and measurable improvement within 30 days. The spread across the company's own materials is wide enough that these should be treated as marketing ranges rather than performance disclosure. Independent signal: CB Insights named RapidClaims an Outperformer in its automated and assisted coding ESP matrix, assessed against fifteen other companies including Oracle, Ambience and Suki. Funding is approximately 11.1 million dollars: an 8 million dollar Series A led by Accel with Together Fund participating, plus roughly 3 million dollars of previously unannounced seed led by Together Fund, with angel investors including Oscar Benavidez of Massachusetts General Hospital and Matthew Zubiller. Reported headcount is between 89 and 96 in mid 2026. Screened against the services filter and retained. The company markets coding outsourcing prominently, but independent profiling across PitchBook, Crunchbase, Tracxn and CB Insights describes a platform, the product line is software, and the outsourcing pages are demand generation rather than the business model. This is the opposite finding from MediCodio, which was rejected in the same sweep.

Vite Clinic is an artificial intelligence phone receptionist sold exclusively to clinics in Switzerland. It answers routine patient calls around the clock, books and changes appointments through the clinic practice management system, and transfers medical, urgent and sensitive calls to clinic staff under rules the clinic sets. It supports Switzerland's four national languages, Swiss German and a stated 40 plus languages in total, and reports answered calls, transfers and outcome mix through a dashboard. The clinic keeps its existing phone number and forwards calls to the service, and controls what share of forwarded traffic the assistant answers. The service is operated by Benjamin Crozat EI, a sole proprietorship registered in France (SIREN 750 497 570, Nice), hosted with Infomaniak in Switzerland, and it publishes a price of CHF 200 per 100 calls after onboarding. NO DEPLOYED CLINIC IS EVIDENCED. The vendor's own trust page, last reviewed 27 July 2026, describes launch checks that occur before patient calls begin and lists production controls that still require launch evidence, and no named clinic customer, deployment figure or completed practice management connector was located in public sources. Grades on evidence, integration depth, security and governance record that absence and are expected to move once deployments exist. The record was opened after the company submitted itself for consideration through the index contact form; it was screened on the same public methodology as any other candidate and no favourable treatment was applied.

Augmedix is the ambient documentation business that kept people in the loop and charges for it. Founded in San Francisco in 2012 by Ian Shakil, who remains chief strategy officer, it listed on Nasdaq before Commure acquired it in July 2024 for around 139 million dollars in equity value at 2.35 dollars a share. It now operates as a wholly owned subsidiary with its own brand, product line and contracts, which is why it holds a record here rather than being folded into its parent's. The product line is organised by how much human involvement a customer buys. Augmedix Live provides synchronous documentation and point of care support with trained documentation specialists working during the visit. Augmedix Go is an autonomous mobile application for lower complexity settings, with Go ED a variant for emergency medicine producing draft notes in moments. Go Assist produces documentation asynchronously from recorded visits, and Augmedix Prep prepares the chart before the patient arrives. Capture is by smartphone or lightweight headset, and a combination of models and trained scribes produces a structured note that reaches the record during or immediately after the visit. The company has invested in automation to reduce the scribe effort behind each note while keeping human review available for complex or high stakes encounters. Its roots are in emergency medicine, hospital medicine and specialty outpatient care, and it served more than 20 major health systems and hundreds of sites of care at the time of acquisition. In January 2025 it was awarded a contract with Vizient covering Go, Assist and Live. Vizient serves more than 65 percent of United States acute care providers and 97 percent of academic medical centres, representing over 140 billion dollars in annual purchasing volume. While listed, the company reported 45 million dollars of revenue in 2023, up 45 percent, against a net loss of 19 million dollars.

Syllable answers the main line and the access centre for large health systems, across voice, text, chat and web. Its reference deployment is Houston Methodist, which put the system in front of every incoming call, answering and routing 100 percent of them before expanding into further use cases over time. The agents take scheduling calls in natural language and book, confirm, reschedule or cancel within the same conversation, writing directly into the source record or practice management system rather than leaving a task in a queue for someone to reconcile afterwards. Prebuilt connectors cover Epic, Oracle Health, MEDITECH and athenahealth, and the platform sits alongside existing contact centre telephony over standard telephony interconnect rather than replacing it, which matters for an enterprise that has already bought a contact centre platform. Scope extends past inbound scheduling into refills, frequently asked questions with context aware warm transfers, inbound and outbound referral scheduling, outstanding balance outreach, clinic level routing, and billing workflows including payment processing and automated balance verification through custom interfaces. Commercially it is the most legible product in this category. Independent 2026 comparisons report an enterprise rate of 3.60 dollars an hour and a trial tier at no cost, and describe the company's pricing page as documenting usage scenarios together with the third party pass through costs of speech recognition, speech synthesis and telephony, which those comparisons characterise as more transparent than its competitors. The same independent reviews note two cautions. Public buyer feedback is thin, so there is little peer review to draw on. And implementation effort is substantial, since escalation policy, routing logic and quality assurance have to be owned by the customer rather than delivered by the vendor.

mPulse reaches health plan members at very large scale and uses models to decide which members to reach. Based in Los Angeles, backed by PSG and previously trading as mPulse Mobile, it describes itself as a health experience and insights company and reports more than four billion consumer touchpoints a year across more than 450 healthcare organisations, including over 50 of the 60 largest health plans and 80 percent of top rated Medicare Advantage plans. It was named a Strong Performer in the Forrester Wave for customer experience platforms in healthcare in the first quarter of 2026, and reported year on year revenue and profitability growth in the same quarter. The platform combines two way conversational artificial intelligence and natural language processing with predictive analytics and omnichannel delivery across text, voice, web, portals and print. A member who texts asking for help finding a doctor receives a provider directory link without a person intervening, and campaigns can hand off to a live agent mid conversation. Real time integration with Epic scheduling supports appointment workflows. Much of the current shape came from acquisition. HealthTrio and Decision Point Healthcare Solutions were bought in December 2023, adding member portals and member experience analytics, and Clarity Software Solutions followed in August 2025, contributing cross channel communication and data from 150 million member communications. Use cases centre on the measures that determine health plan revenue: medication adherence for Star Ratings, preventive screening and quality measure gap closure, member acquisition and retention, and access to care. A published case study describes a Medicare Advantage plan using predictive analytics to identify both the members most likely to rate the plan poorly on the federal experience survey and the members most likely to respond positively to outreach, then targeting calls, mailers and issue resolution accordingly. It reports that members who received outreach disenrolled at 2.7 times a lower rate, that roughly 186 members were retained, worth more than 1.1 million dollars over three years, and a return of 776 percent by the third year.

Relatient runs patient access at scale: its Dash platform serves more than 50,000 providers and over 150 million appointments a year, and it won Best in KLAS in 2024 for patient self scheduling and engagement software. It is based in Atlanta. The platform combines online self scheduling, centralised call centre scheduling, automated messaging and a voice agent, all sitting on one rules engine that encodes each provider's scheduling preferences and constraints. Dash Voice AI answers calls, books, cancels, reschedules and confirms appointments with what the company describes as zero staff intervention, and posts updates back to the record or practice management system in real time. A caller can either complete the booking on the phone or be sent a secure text link to finish online. The design argument worth understanding is that the voice agent uses the same rules engine as the human schedulers. Its constraint comes from configuration rather than from model behaviour, so it cannot book something a human scheduler would not, which is a different kind of safety property from the confidence thresholds most voice vendors describe. In July 2026 the company extended the agent beyond scheduling into clinical request automation. It now captures a patient's clinical, medication or billing request during the call and creates an actionable task for the right care team inside existing workflow tools, replacing the cycle of listening to voicemail, transcribing and entering the task by hand. Integration spans the major record and practice management systems, including Epic, Oracle Health, athenahealth, NextGen, Veradigm and ModMed, through application interfaces and health data standards. The company states HITRUST, SOC 2 and HIPAA compliance with single sign on. Named customers include Raleigh Orthopaedic, Western New York Dermatology, and Complete Health, which is reported to generate more than 60,000 self scheduled appointments a month.

Phreesia is the incumbent of patient intake. Founded around 2005 by chief executive Chaim Indig, listed on the New York Stock Exchange since 2019 and employing roughly 1,550 people, it reported 4,514 client organisations and more than 180 million patient visits enabled in 2025, both figures disclosed in securities filings rather than in marketing. The platform spans check in, appointment readiness, clinical and administrative data capture, consent, eligibility verification, time of service collection and patient payment, extended by the acquisition of the patient financing business AccessOne. It holds what independent analysis describes as the broadest record system connector library in its category, including an Epic listing, and publishes an unusually complete compliance position: HITRUST r2, SOC 2 Type 2 and PCI DSS Level 1. Artificial intelligence arrived recently and the company is candid that it is not the centre of the business. Phreesia VoiceAI, launched in September 2025, answers the practice telephone: refill requests with medication and pharmacy captured, balance enquiries and payments, medical records requests routed to the right team or release of information partner, clinical questions captured and triaged, and referral handling. Separately the company describes applying artificial intelligence internally to reduce reliance on manual and outsourced work, which it presents to investors as a source of margin expansion. Its chief executive has said publicly that artificial intelligence is a tool rather than the story. The third revenue line is the one a reader should understand. Network Solutions uses what the company calls the engagement window during intake to deliver messaging funded by life sciences companies, government bodies and advocacy organisations directly to patients. In March 2026 Phreesia reported its first year of positive net income and simultaneously cut fiscal 2027 revenue guidance to between 510 and 520 million dollars, citing reduced visibility into pharmaceutical spending; the shares fell sharply and securities class actions were filed in Delaware in May 2026 concerning that guidance. That is investor litigation about disclosure, not about the product.

Element5 automates the back office of post acute care: home health, hospice, skilled nursing and senior living. It is based in San Jose with a second headquarters in Chennai, was co founded around 2020 by chief executive Joe Randesi and chief revenue officer Eric Gordon among others, and has raised 48.5 million dollars, with both a 15 million dollar Series A in 2021 and a 30 million dollar Series B in 2022 led by Insight Partners. The origin is robotic process automation. The company's own early description was of trained robots that log into everyday systems and perform administrative tasks exactly as a person would, saving teams hours of repetitive clicks. That heritage matters when reading the current product, because another vendor in this index builds its whole architectural argument against precisely this approach, on the ground that recorded screen interactions break whenever a payer changes a portal. The platform has since moved toward agentic automation under the name Neos, described as a modular end to end solution spanning the patient financial journey, with eligibility and authorisation handled across a connected network. The workflow list is specific and long: insurance eligibility verification at admission and during episodes, authorisation processing including polling convenor portals for status changes, hospice benefit period verification, denial categorisation with prioritisation of high value cases, claims submission, cash posting, notice of admission and notice of election filing, physician order exchange, and the transition of assessment data into the federal reporting system. The company positions itself as a bridge between record systems, payers, convenors and clearinghouses, and offers building blocks so customers can deploy their own agents for unusual payer or local workflows. Distribution includes a partnership with Homecare Homebase, the post acute record system that states it serves around 37 percent of United States home health and hospice providers. Named customers in published case studies include VNA Health Group, VIA Health Partners, Vivie and Buckeye Home Health. The company was named to the CB Insights Digital Health 150.

Humata Health automates prior authorisation end to end, and its distinguishing claim is that the process can be made touchless: a clinician enters an order in the record system, and the platform determines whether authorisation is required, assembles the clinical documentation that supports it, and submits it, without further human involvement. In February 2026 Allegheny Health Network was named the first United States health system to run medical prior authorisation that way from order to approval. The company is based in Winter Park, Florida and was founded in 2023 by Jeremy Friese, a radiologist trained at Mayo Clinic and Harvard who is chairman and chief executive. He had earlier co founded Verata Health, which the health automation company Olive acquired in 2020, and served as a president of Olive; when Olive wound down, its remaining assets went to Waystar and to Humata. It raised 25 million dollars from a syndicate that is notable for who is in it: alongside Blue Venture Fund, LRVHealth and .406 Ventures sit Optum Ventures and Highmark Ventures, both arms of large payer organisations. The positioning is provider side and the company describes itself as built for yes, but it operates across the divide. It integrated the intelliPath technology of EviCore by Evernorth, a utilisation management business, so that provider clients reach a broad payer network. In June 2026 it launched what it describes as the first artificial intelligence enabled prior authorisation portal designed for providers rather than payers, extending beyond large health systems to independent practices, regional centres and specialty clinics. Its technology has also been made available within Microsoft Dragon Copilot. It sits inside the federal reform of this process as well. It joined the Centers for Medicare and Medicaid Services electronic prior authorisation acceleration initiative, and was selected as a technology partner for the WISeR model, standing for Wasteful and Inappropriate Service Reduction, which went live in January 2026 and applies artificial intelligence driven clinical review within Medicare. The company also supports an industry commitment to return more than 80 percent of prior authorisation decisions in real time by 2027.

HiLabs cleans healthcare data that other systems then rely on, and its centre of gravity is the provider directory. Founded in 2014 by chief executive Amit Garg and Neel Butala, based in Bethesda, Maryland, it employs around 340 people across four continents and has raised roughly 41 million dollars, including a 39 million dollar Series B in March 2024 led by Denali Growth Partners and Eight Roads Ventures with F-Prime Capital. The platform is MCheck, which ingests, cleans and enriches data for health insurers across provider data accuracy, clinical results, payment accuracy and value based care. The provider directory product validates and enriches more than 60 attributes per clinician, from phone numbers and specialties to whether a practice is accepting new patients, by cross checking signals across thousands of sources on a recurring cadence rather than through periodic one off cleanups. The company states the directory solution is live in most United States states and analyses data covering more than 80 percent of the country's healthcare providers, and it works with CAQH, whose provider data it combines with its own models. The evidence position is unusual for an administrative product. The company's method has been validated in peer reviewed research published in the Journal of the American Medical Association and referenced in a MedPAC report to Congress. The published work found that more than four in five physicians listed in health insurer directories had inconsistent entries, which bears directly on whether the provider directory provisions of the No Surprises Act are being met. The portfolio has since widened. MCheck NetworkIQ was deployed with a national behavioural health organisation serving millions of members. In August 2026 the company announced MCheck Intelligent Outreach, an agentic voice platform that calls providers to confirm and update their directory details, deployed by one of the ten largest United States health plans. Growth leadership includes president and chief growth officer Amir Desai and chief growth officer Robert Renzi.

Iodine Software reads every inpatient chart, continuously, and predicts where the clinical record and the documentation have come apart. Founded in 2010 in Austin, Texas, it won Best in KLAS for clinical documentation integrity in both 2022 and 2023. It is no longer independent. Waystar, the listed healthcare payments software company, completed its acquisition of Iodine on 1 October 2025 for a total of about 1.25 billion dollars, roughly half cash and half stock, buying it from shareholders led by the private equity firm Advent International. Waystar stated at closing that Iodine brought a client base of more than 1,000 hospitals and health systems and expanded its addressable market by over 15 percent. Iodine continues to trade under its own name as part of Waystar, which is why it holds a record here, and a buyer should understand they are contracting with a division of a listed payments company rather than a standalone vendor. The engine is called CognitiveML, and the company describes its approach as cognitive emulation: rather than applying rules to a chart, the models are built to mirror how a clinician reasons about a case. It draws on what the company states is one of the largest inpatient clinical datasets in the country, described as 1.5 billion medical concepts across millions of admissions, and now blends generative models and large language models with the earlier natural language processing and machine learning. The suite has widened well beyond documentation. Concurrent, launched in 2015, gave documentation teams real time visibility into charts. AwareCDI addresses documentation integrity across the middle of the revenue cycle. AwareUM, launched in February 2024, applies the same engine to utilisation management, prioritising cases for review and supporting medical necessity discussions with payers, and the company states it provides transparency and reasoning behind its predictions. AwarePre-Bill followed in May 2025, framed as right sizing reimbursement before a claim goes out. Two further companies were absorbed earlier and no longer trade independently: Artifact Health, a physician query platform, and ChartWise, a documentation integrity vendor. Reported results are financial rather than clinical. The company states its documentation suite helped hospitals recognise 1.5 billion dollars in additional appropriate reimbursement annually, and that in 2024 it helped health systems recover more than 2.1 billion dollars.

Machinify is the largest payment integrity organisation in the United States market and it exists as the result of four companies being combined under one private equity owner. Anyone searching for the constituent brands is looking at businesses that now sit inside this one. The sequence matters. In September 2024 New Mountain Capital merged The Rawlings Group, Apixio's Payment Integrity business and VARIS into a single platform. In early 2025 it acquired Machinify Inc, an artificial intelligence software company founded in 2016 in Palo Alto, and named the whole combined entity Machinify, with David Pierre as chief executive. In October 2025 the group acquired Performant Healthcare for a reported 670 million dollars, and through 2026 the Rawlings brand was retired into Machinify. Reported valuation at the time of the Machinify acquisition was around 5 billion dollars on revenue above 500 million. One split is worth recording precisely because it is the kind of detail that causes confusion. Only Apixio's payment integrity business went into this group. Apixio's Connected Care platform and value based care solutions were acquired separately by Datavant, so the Apixio name divided between two acquirers rather than moving as one. What the combined organisation sells to health plans spans subrogation, coordination of benefits, pharmacy payment integrity and complex claim review, delivered as what the company describes as a cloud based data intelligence platform for deploying purpose built artificial intelligence across the payment continuum, supported by clinical expertise and a large claims data asset. Company materials report service to more than 60 health plans, with some sources citing 75 to 85, including many of the twenty largest, alongside expansion into government programmes. An independent assessment worth noting alongside that: analyst trackers continue to place Cotiviti and Optum as the entrenched leaders in enterprise scale payment integrity, describing this company's market leadership as still emerging despite its scale.

Fathom is a San Francisco company selling autonomous medical coding: clinical documentation arrives from the record system after a visit, deep learning and large language models assign the codes, and complete results return for claim submission without a human coder touching most encounters. Chief executive Andrew Lockhart co founded it. Sources disagree on the founding year, giving 2015 and 2017. Coverage spans the full set of elements a coder assigns rather than a subset: diagnosis codes, procedure codes, evaluation and management levels, modifiers, provider assignment, units, shared services and documentation deficiencies, across specialties. Turnaround is stated at under two hours for a day's encounters, averaging 57 minutes. The published figures are unusually specific. Around 90 percent or more of encounters are coded autonomously or correctly flagged for documentation deficiency, accuracy is stated above 96 percent with ongoing audit programmes, and cost to code falls by 30 to 50 percent with a stated average of 42.3 percent. A customer, Your Health, reported a 95.5 percent automation rate at 98.3 percent accuracy across all service lines in March 2026. Two commitments distinguish it from the category. The company offers contractual service level agreements guaranteeing automation rate, accuracy and turnaround time, which converts published performance into an enforceable obligation. And it offers a risk free trial in which a provider validates coding quality on their own encounters before production models are switched on. Independent recognition includes a KLAS Spotlight report in September 2024 reporting 100 percent high customer satisfaction and validation of automation rates above 90 percent, and the top position for reducing the cost of care in the 2025 KLAS Emerging Solutions report. The company holds HITRUST i1 certification, obtained December 2024. It has raised roughly 61 million dollars from investors including Lightspeed Venture Partners, Alkeon Capital Management, Inflect Health, Tarsadia Investments and the Cedars-Sinai Accelerator, with a later strategic investment from CVS Health Ventures.

Pabau is a practice management platform for private clinics and medical spas, and the artificial intelligence product inside it is Pabau Scribe, an ambient medical scribe that generates structured clinical notes from a consultation. The wider platform covers booking, the clinical record, digital intake and consent forms, injection plotting and body mapping, before and after photography, prescriptions, payments, inventory, marketing and reporting, and the company states it is used by more than 3,500 healthcare practices worldwide. The scribe itself publishes an oversight step most competitors leave implicit: notes are generated ambiently and reviewed by the clinician before entry into the record. It offers configurable specialty templates and documentation frameworks built for aesthetic and wellness treatments, and the company's stated design argument is that keeping documentation inside the same platform as the record avoids passing patient data to an external tool with separate governance obligations. It operates on both sides of the Atlantic, built for United Kingdom and European data protection law as well as United States health privacy law, and is registered with the United Kingdom Information Commissioner's Office under reference ZA478121. It states plainly that the clinic remains the data controller and that Pabau acts as processor. One disclosure on its trust portal deserves particular attention and is treated at length in the security note. Pabau publishes a set of certificates covering payment card standards, health privacy attestation, ISO 27001, the European operational resilience regime and cloud security, and states directly that these belong to the cloud and data centre providers hosting the platform rather than to Pabau itself. Founding year and headquarters were not confirmed in this pass and are left blank rather than guessed.

FinThrive is a healthcare revenue cycle management software company selling a broad suite to hospitals and health systems rather than a single product. Its stated scope covers patient access, charge and revenue integrity, claims and contract management, automation, analytics and education, and the company reports more than 4,100 customers including over half of United States hospitals and health organisations. The technical centre of the current strategy is FinThrive Fusion, described as a data intelligence platform built specifically for healthcare revenue operations, which unifies financial and payer data across the enterprise. On top of Fusion the company markets agentic artificial intelligence: autonomous agents that identify risk, orchestrate next best actions and execute work across the revenue cycle. At HIMSS 2026 it presented more than 50 artificial intelligence and automation use cases and positioned artificial intelligence as the operating model for revenue management rather than an added feature. Named products include Denials Prevention Manager, aimed at denials that are written off or missed entirely, and Community Advantage, a package for rural hospitals and community health systems under financial pressure. The company publishes an annual Transformative Trends survey of revenue cycle leaders, now in its third edition, whose 2026 findings included that more than 70 percent of respondents expect to reduce reliance on third party revenue cycle vendors and nearly 60 percent plan to consolidate vendors within three years, a trend the company's own consolidation pitch is built to serve. It was ranked by Black Book Research in three revenue cycle management categories in 2025. Its chief information security officer is Greg Surla. Founding year and headquarters were not confirmed in this pass and are left blank rather than guessed.

Fabric sells what it calls a care enablement system: conversational intake, triage, routing and treatment across virtual and in person care, sold to health systems, health plans and employers. It was founded in 2021 as Florence by Aniq Rahman, is based in New York, and rebranded to Fabric in 2024. The company is a roll up and that is the most important thing to understand about it. Five acquisitions in under three years assembled the product: Zipnosis, an asynchronous virtual care platform bought from Bright Health in April 2023; GYANT, a conversational artificial intelligence and patient engagement company bought all cash in January 2024, whose co founder Stefan Behrens became chief strategy officer; MeMD, bought from Walmart, which added payer and employer distribution; and TeamHealth Virtual Care, which added a 50 state clinical network of actual clinicians. Anyone searching for Zipnosis, GYANT or MeMD as separate companies is looking at brands that now sit inside this one. The product is organised as three suites covering in person care, virtual care and engagement, with a layer the company calls Hybrid AI that pairs conversational models with physician authored clinical logic and customisable decision trees. It raised a 60 million dollar Series A in February 2024 led by General Catalyst with Thrive Capital, GV, Salesforce Ventures, Vast Ventures, BoxGroup and Atento Capital, taking total funding past 80 million dollars. Named customers include OSF HealthCare, MUSC Health, Luminis Health and Intermountain, and the company stated coverage of more than 100 million lives as of September 2024. Published operational claims include clinicians working two to ten times faster depending on setting and a 15 percent reduction in call centre volume, and the acquired asynchronous product was described as automating 99 percent of administrative work with low acuity conditions treated in 89 seconds.

Medsender is a New York based healthcare workflow automation company whose product reads the documents and phone calls arriving at a medical practice and files what it finds into the electronic health record. It began in 2014 as a HIPAA compliant digital fax service and the automation layer came later, which is still visible in the product shape: fax transport, document editing, electronic signature and storage sit underneath, and the artificial intelligence is sold on top of them in named tiers. The platform has four parts. Fax automation reads each inbound fax, titles it, categorises it, tags it and uploads it to the correct patient chart, with new chart creation where none exists. Referral management classifies and routes inbound referrals into a dedicated workflow before a coordinator touches them, and reports status back to the referring provider. The AI Medical Assistant, branded MAIRA, answers inbound patient calls, schedules appointments, handles routine questions and produces recordings, transcripts and call summaries. A developer fax interface exposes the same extraction to other health technology companies through typed software development kits, webhooks and sandbox access. Integration is the strongest published surface for a company of this size. Named ambulatory electronic health record connections include athenahealth, eClinicalWorks, ModMed, NextGen, Practice Fusion and Ezderm, and an integration guide is published. The company raised a 5 million dollar Series A led by Ballast Point Ventures, announced January 2025, and is led by co chief executives Zain Qayyum, who founded it, and Salman Haque. Sources disagree on the founding year: company registries record 2014 while the founder dates it to 2015 in interviews. Extraction accuracy is claimed at 99 percent, but the figure appears as a customer testimonial in marketing copy rather than as a measured result, with no test set, denominator, document mix or independent validation. No model is named or described anywhere in public material.

Luma Health, founded in 2015 in San Francisco by Adnan Iqbal, Aditya Bansod and Tashfeen Ekram, sells what it now calls an operational artificial intelligence platform for health system patient access. The company states it works with more than 550 health systems, hospitals and clinic networks, has served more than 30 million patients, and integrates with more than 80 record and practice management systems. It raised 160 million dollars through a 130 million dollar Series C led by FTV Capital in November 2021, with Texas Medical Center and DocuSign Ventures among strategic investors. No later round was located. The artificial intelligence core is Spark, announced in 2024 and described as multi model and zero retention, and the company names the providers behind it, including models from OpenAI, Anthropic and Deepgram, fine tuned for healthcare. The patient facing voice product is Navigator, an agentic concierge that answers inbound calls in multiple languages, verifies a caller's identity, lists and confirms appointments, cancels directly in the record system and handles prescription refill requests. Its engineering lead describes the design plainly as several cooperating agents, each a model with a prompt and a set of tools, one verifying identity, another listing appointments, another cancelling. Alongside Navigator sit Fax Transform for inbound document processing, LumaPay for point of service payments, eligibility checking, self scheduling, waitlists and, from August 2026, Patient Pipeline, which converts advertising spend into booked appointments for organisations running Epic. The company reported deployment of artificial intelligence workflows at more than 50 health systems and more than 2 million hours of staff time saved during 2025, and says a 2026 release will extend the conversational agent to proactive outbound follow up driven by record data, visit notes and prescriptions. Integration is built in house rather than bought, spanning Oracle Health, Epic, eClinicalWorks, MEDITECH, athenahealth, NextGen and Greenway Health, with inaugural membership of the MEDITECH alliance programme and validated integration status with Oracle. Chief product and technology officer Marcelo Oliveira. Research and development centres in the United States, Brazil and Europe.

Parlance Corporation, founded in 1996 and based in Woburn, Massachusetts, sells conversational voice artificial intelligence for the health system telephone: the switchboard, the patient access contact centre and the clinic front desk. Its speech lineage runs back to research at BBN Technologies, now part of Raytheon. The company states it serves more than 400 health system brands across the United States, Canada and the United Kingdom, has answered more than 1.9 billion patient calls, and sustains a rate above six calls per second. Named customers include HCA Healthcare, running it across more than 75 hospitals with over 70 percent of calls handled automatically, UW Medicine at close to 4 million calls a year, and Virtua Health, which doubled annual call volume from 200,000 to 400,000 without adding contact centre staff. Providence Health, NYU Langone Health, Banner Health, Baptist Health, Keck Medicine of USC, Arkansas Children's, Tufts Medical Center, UC San Diego Health and Hendrick Health are also named. Callers speak naturally instead of navigating a menu. The system routes across departments and locations, answers common questions, books and manages appointments against live schedules, reports prescription and referral status, and hands complex calls to a human agent with context already populated on the desktop. Patient room directory routing runs on HL7 feeds. The July 2026 Parlance 12 release added semantic routing, which passes an unresolved caller intent to a large language model rather than dropping the caller straight to an operator, alongside improved first pass recognition and a modernised synthesised voice. Delivery is a fully managed service: the vendor hosts, monitors, tunes and updates the platform while the health system sets scheduling guidelines and escalation rules. Parlance was acquired by Volaris Group in 2024 and is a wholly owned subsidiary of Constellation Software, a Toronto listed acquirer operating a stated buy and hold strategy across more than 1,100 software businesses. Chief executive Scott D'Entremont.

Verbal AI Technologies, founded in 2024 and led by co founder and chief executive Waleed Mohsen, audits healthcare interactions for compliance rather than conducting them. It sits alongside an organisation's existing communication systems, logs every call, and analyses call transcripts in real time and retrospectively together with clinical notes and secure chat messages, checking each against the organisation's own written clinical, safety and billing protocols. Models are trained per customer on that customer's compliance requirements across roles and service lines, and the customer validates the model's accuracy before it is released to users. Outputs include adaptive compliance checklists, audits of clinical notes for completeness and regulatory adequacy, detection of documentation gaps and inconsistencies, topic analysis across an entire interaction history, and conversational measures such as speaking pace, talk to listen ratio and sentiment, surfaced through dashboards tracking adherence and compliance trends. The company frames its position against ambient scribes directly, arguing that summarising a conversation is not the same as evaluating it. One characteristic sets this record apart from everything else in this index: the platform audits clinical notes whether a human or an artificial intelligence agent produced them, and the company names agent developers as a customer type alongside healthcare organisations. In October 2025 it was named a qualified solution on Mayo Clinic Platform, making it available to that network's affiliated organisations.

Weave, based in Lehi, Utah and listed on the New York Stock Exchange under the ticker WEAV, sells a patient communications, engagement and payments platform to small and medium healthcare practices, serving roughly 40,000 customer locations concentrated in dental and optometry with medical, veterinary and multi location enterprise practices alongside. The original business combined a practice telephone system with texting, digital forms, payment collection and review management, and the artificial intelligence has arrived on top of that distribution position rather than underneath it. In May 2026 the company launched an omnichannel AI Receptionist built with Google Cloud's Gemini Enterprise Agent Platform, which handles patient interactions across voice and text, preserves context so a patient starting on the phone and continuing by message never repeats themselves, routes conversations, and transitions to staff inside one workflow. A July 2026 release expanded that receptionist, added automated digital insurance capture and introduced stronger authentication for enterprise customers, with the company's own operating lead stating that larger customers are asking for more visibility into how the artificial intelligence performs. Authorised integrations with practice management systems drive scheduling, insurance eligibility verification and payment collection. Notably for this index, Weave names the model platform underneath its agent, which most vendors in this segment do not.

TeleVox is a long established healthcare patient engagement and communication business that built its reputation on automated telephone appointment reminders and now sells an omnichannel platform covering text, voice, email and physical mail. Its Enterprise Edition positions itself as unifying the channels that otherwise reach a patient separately from the call centre, the record system and the customer relationship system. The artificial intelligence sits in a named product layer rather than across the whole platform: Engage, described as powered by conversational artificial intelligence, handles inbound and outbound patient communication with conversational responses, self service appointment management, bill pay and prescription refills, and hands off to live chat when the conversation exceeds it. The ownership history is worth reading carefully. TeleVox Software was acquired by West Corporation in March 2007 in a deal valued at around 128 million dollars. West was renamed Intrado, then taken private by Apollo Global Management in October 2017 at an enterprise value of roughly 5.2 billion dollars, and later became West Technology Group. In February 2024 that owner appointed banks to explore a sale of TeleVox specifically. No completed sale was located, and current material from a sibling brand indicates TeleVox remains inside West Technology Group: Mosaicx states that its president leads WestCX, a unified platform overseeing the Mosaicx and TeleVox brands, with that executive joining in 2025. So TeleVox appears to have been retained and grouped with a sibling conversational artificial intelligence product rather than divested, though no announcement confirming the outcome of the 2024 process was found.

Switchboard, MD is an Atlanta company founded in 2022 that triages, routes and resolves the high volume patient communication arriving at a healthcare organisation across the portal inbox, live calls, voicemail, fax, text, email and web forms. It began with a specific problem its founder had personally: Dr Blake Anderson, a practising internal medicine physician at Emory Healthcare and previously chief health informatics officer at the Atlanta Veterans Affairs facility, applied a computer science background to build a language model that triages patient messages inside the medical record and routes each one to the correct inbox, removing roughly 40 percent of the messages that had been reaching clinicians. Those results at Emory were published in the New England Journal of Medicine artificial intelligence journal in 2025, which is the only peer reviewed publication located for any vendor across two contact centre source lists. The platform now adds conversational voice handling, multi agent orchestration, autonomous scheduling for high volume visit types, appointment reminders, wayfinding, and referral capture that classifies an inbound referral, creates or updates the patient record, routes it to a provider and drives booking. Models summarise, classify, prioritise, flag clinical urgency and assess caller sentiment. It is deployable on premise or in the cloud, states that the customer's data remains the customer's, and describes the platform as HIPAA compliant and certified to SOC 2 Type 2. It joined the athenahealth marketplace as a solution partner in July 2026. Named customers include Kirby Medical Center, a critical access hospital in Illinois, and Georgia Vision Institute.

ActiumHealth is the healthcare branded patient communication product of Syllable, a Mountain View company that purchased it in March 2024 and now runs it as a division. The name has outlasted both an ownership change and a product change, which is the first thing a buyer should understand about it. It began in 2017 as SymphonyRM under founder Michael Linnert, a patient relationship intelligence product built on the argument that record system data was underused for identifying who needed outreach, and raised roughly 36.5 million dollars across a 10 million dollar Series A in 2019 and a 25 million dollar Series B in May 2021 led by TT Capital Partners with Adams Street. Under Syllable the product described is generative communication automation rather than predictive outreach intelligence, and the company reports more than 70 million calls handled with roughly 70 percent resolved without a person, across inbound and outbound voice, text message, chat and email, in several languages including Spanish and Mandarin. Houston Methodist is named publicly as a reference with a stated staffing capacity gain. Agents identify a caller, find the right provider or department, check availability and confirm appointments, take prescription refill requests into the clinical workflow, and escalate out of scope requests to a human operator with the full conversation context attached so the patient does not repeat themselves. Escalation routing changes by time of day, with urgent clinical questions going to the on call provider after hours while scheduling and refill requests queue for the next business day. A quality monitoring layer launched in October 2025 analyses the calls the agents themselves handle and flags problematic interactions for intervention. Integration with the dominant electronic health record vendor is published as a named product surface. The wider position is worth watching: through 2026 the parent has repositioned as a general purpose agentic voice platform with published gateway services for language models, speech recognition and speech synthesis, a self service sign up and a public showcase spanning home services, mortgage, retail commerce and automotive alongside healthcare. Chief operating officer Carter Dunn. John Voigt was appointed executive vice president for growth and strategy in September 2025.

Flexbone builds artificial intelligence agents for the back office of outpatient healthcare, deliberately aimed at the organisations large vendors skip. Its strategic argument is stated plainly: the great majority of outpatient facilities do not run Epic or Cerner, the best funded competitors have built for Epic, and the rest of the market is left to systems nobody integrates with. Flexbone's answer is multi modal agents rather than interfaces. Voice agents answer and place calls for scheduling, triage, post operative follow up and payer follow up, navigating payer phone menus and holding on the line. Browser agents log into practice systems and payer portals the way a member of staff does, verifying eligibility across more than 25 portals and submitting prior authorisations where no interface exists. Document agents ingest denial letters, classify the cause against the encounter and republish corrected claims to clearinghouses. Voice Room, the product named on this list, plugs into an existing telephone system and analyses every call rather than the small sample manual quality review reaches, producing sentiment, compliance monitoring and automated scoring. Named system targets include Tebra and an ambulatory surgery centre platform. The company publishes entry pricing, begins engagements with a no cost operational audit, and embeds forward deployed engineers during implementation.

Attuned Intelligence, based in Orlando under co founder and chief executive Domenic Donato, emerged from stealth in October 2025 with 13 million dollars in seed funding led by Radical Ventures and Threshold Ventures. It answers the main telephone line of a hospital or health system with voice artificial intelligence, and states that it resolves up to 70 percent of interactions without a person. The distinguishing claim is architectural rather than functional: every call is described as running on a stack of several specialised agents working together, some parsing what the caller means and others enforcing safety policy and escalation rules, with operations leaders given real time visibility into how each decision was made. Deployment is published as a staged path, forwarding the main line and going live within days, then setting escalation rules, then integrating with the record system over subsequent weeks for scheduling, messaging and records access. The reference deployment is Lowell Community Health Center, a safety net provider serving 40,000 patients a year, live in ten days and now answering every call to its main line around the clock across multiple languages, covering everything from emergencies and medication questions to billing and records. Another health system is described as taking nearly 50,000 calls a week. The company states it is onboarding multiple hospitals per week.

Authenticx, founded in Indianapolis by former healthcare executive Amy Brown, analyses the conversations healthcare organisations have with patients and members across voice, chat and email, and reports what those conversations reveal at a system level rather than call by call. Its models are described as trained exclusively on healthcare data using a proprietary labelled corpus. The signature one is the Eddy Effect, a friction model that locates the points where people get stuck, confused or lost, and connects those points to consequences a business recognises such as therapy discontinuation, prescription fills and retention. A separate generative model transcribes and summarises conversations for evaluation, and further models cover agent quality, sentiment, unsupervised topic discovery, compliance monitoring and adverse event signal detection. An agent assist product released through the Salesforce marketplace in late 2025 puts historical context, real time guidance and recommended next steps in front of the person on the call, and evaluates interactions against defined rubrics. Customers span pharmaceutical manufacturers, including Eli Lilly for adverse event signal identification, along with insurers and provider contact centres. The company raised 20 million dollars in Series B funding in January 2023 led by Blue Heron Capital.

Attune, based in Chicago and publicly launched in January 2026 under chief executive Matt Coughlin, sells Agentic Voice, an autonomous voice system that holds telephone conversations with patients and health plan members on the organisation's behalf. Rather than following a fixed script, the agent is described as pursuing a goal across multiple steps: identifying a gap in a care plan, placing an outbound call, checking a live schedule, booking an appointment and confirming it, without a person in the loop. It reads and writes through interfaces and webhooks, escalates to staff with the full conversational context attached, retries on failure, and reports sentiment rather than only call metrics. It also navigates phone trees and holds on the line, which extends its use to calls the organisation makes outward as well as inward. The case the company puts forward is a health plan that used the agent to work through its entire Medicare member population completing health risk assessments. Note for readers of this list: despite appearing on a source list of agent assistants, this product does not assist a human agent, it replaces one, which is why it sits with the patient facing voice agents. The company is roughly six months into public operation and much of what this index grades is not yet published.

Laguna Health, founded in 2020 by Yoni Shtein and Yael Adam and based in New York, applies conversational models to the calls that care managers hold with members, principally in the period after a hospital discharge. Its framing is contextual care: a member's record describes their medicine but not their life circumstances, their caregiver's situation or the emotional and practical obstacles that actually determine whether a recovery plan is followed, and those obstacles surface in conversation rather than in data fields. The platform prepares the care manager before a call, surfaces insight during it, drafts the documentation afterward in the style and format each organisation requires, and routes what it heard into care plan changes. A separate product, Laguna Insight, analyses every member interaction on behalf of team leaders and scores whether a care manager noticed and explored the barriers a member hinted at, replacing the practice of supervisors listening to recordings by hand. Buyers are health plans, employers, post acute and home health providers and integrated delivery networks, with quality measure performance an explicit driver. The company has raised over 21 million dollars, including a 15 million dollar Series A in 2023 co led by SemperVirens and HC9 Ventures.

Infermedica, founded in Poland and operating globally, builds clinical triage that guides a patient from an undifferentiated symptom to the right level of care. Its Medical Guidance Platform runs a dynamic question and answer flow over a physician curated knowledge base covering roughly a thousand symptoms and conditions, with a probabilistic inference engine that computes likely causes and urgency and chooses which question to ask next, and a continuous validation process testing the engine against clinical vignettes. Machine learning is used in controlled feedback loops to refine the model against real clinical outcomes rather than as the primary reasoning mechanism, a characterisation that appears both in the company's own material and in the integration documentation of a major cloud partner. Modules cover patient self triage, pre visit intake, and a nurse triage assistant, delivered through modular interfaces that embed into websites, applications, portals and call centres in 24 languages. The regulatory position is the strongest in its segment: the platform is certified as a Class IIb medical device under the European medical device regulation and registered with the United Kingdom regulator, alongside ISO 13485:2016 for medical device quality management, ISO 27001:2022 for information security, and a SOC 2 Type 2 report. It states deployments with ministries of health and national health systems across more than 30 countries.

Popai Health, founded in 2024 by chief executive Eyal Gurion with chief product officer Michael Latar, applies healthcare trained voice models to the phone calls that care coordination teams make and take. The company's argument is that roughly two thirds of patient interaction happens by telephone and almost none of it is captured, so the richest source of clinical, operational and social information in a health system evaporates as soon as the call ends. The platform is described in three layers: it ingests conversations from any call channel and handles medical terminology across multiple languages; it makes the aggregate content of every call explorable through dashboards and reports rather than through manual spot check sampling; and it acts, generating compliant documentation into the record, surfacing real time talking points to the person on the call, and triggering escalations to physicians, appointment scheduling, care gap closure and medication adherence follow up. At population level it surfaces risk patterns across thousands of calls. It raised 11 million dollars in November 2025 led by Team8 and New Enterprise Associates with Essen Health Care participating, and states deployment at Essen Healthcare and Clover Health across more than 18 million minutes of patient conversation. Its site publishes a SOC 2 badge and a HIPAA compliance badge.

TransformativeMed, based in Seattle under chief executive David Stone, sells the CORES Platform, a set of clinician facing workspaces embedded directly inside the electronic health record rather than sitting alongside it. Built originally on the Cerner MPages extension toolkit and now positioned around Oracle Health Millennium, with Epic deployments as well, it reorganises record data into specialty specific views: patient lists carrying each patient's current issues, rounding preparation, handoff, discharge readiness, task synchronisation across the care team, alert routing through Core Notify, secure messaging, and disease specific modules including one for diabetes. A mobile companion both reads from and writes back to the record. Its own founding description of the method is a proprietary knowledge engineering process, which is configuration and clinical content design rather than a learned model, and the artificial intelligence in the current product arrives largely through a September 2025 partnership with Vantiq, whose real time platform supplies the agentic capability. The company was named 2026 Best in KLAS winner for clinician digital workflow, and has run at University of Washington Medicine, University of Alabama at Birmingham, University of Tennessee Medical Center, a Veterans Affairs division and King Faisal Specialist Hospital.

Azra AI, founded in 2022 in Tennessee by Chris Cashwell and formerly named Invenero Holdings, reads pathology and radiology reports the moment they land in the record and turns what it finds into work that someone is accountable for. Natural language models, stated to be trained on more than 100 million pathology and radiology reports through an exclusive partnership with a large United States health system, identify and classify newly diagnosed cancers and flag suspicious incidental findings, and the platform then carries the patient through navigation, tumour board case management, registry abstraction in the national reporting format, and service line analytics. In April 2026 the company acquired Thynk Health, which specialised in lung cancer screening and incidental findings management, and states that the combined platforms run at hundreds of hospitals including five of the ten largest United States health systems, processing well over half a billion clinical reports and messages a year in real time. A clinical research platform launched in May 2026 extends the same report ingestion into trial matching and into cardiology and neurology. The distinction that places this record here rather than in a diagnostic category is that for its original oncology use the pathologist has already made the diagnosis; Azra finds the patient, not the cancer.

Clinical assistant from Doximity, free to verified United States clinicians and reached inside the professional network the company has operated since 2010. Naming is currently in flux across the company's own material, appearing as Doximity GPT, DoxGPT and, in the support documentation, Doximity Ask. A separate record covers Doximity Scribe, the ambient documentation product; this record covers the assistant, following the product scoping rule that splits one company across records where the products serve different jobs. The evidence side has grown into the substance of the product. It answers clinical questions with referenced responses, gives direct access to peer reviewed literature, and lets a clinician select preferred journals and sources which are then prioritised in later answers, which is a degree of user control over the corpus that nothing else in this category offers. A peer reviewed drug reference covering more than 3,200 monographs with dosing, adverse effects and interactions is integrated alongside it. The company draws an explicit line inside its own product between where it retrieves and where it generates. Drug answers are stated not to be generated on the fly but returned from a structured peer reviewed dataset, and the material contrasts that with what it calls guesswork. Output is shaped for clinical reading, with conclusions placed first and comparisons presented as tables. The rest of the surface is documentation and correspondence: chart notes, discharge summaries, prior authorisation and appeal letters, patient education materials, multilingual translation, and coding assistance, with attachments for uploading labs or notes and saved projects for recurring templates. Secure messaging and fax sit alongside for sending material. Published commitments state encryption in transit and at rest, sessions private to the individual clinician, and prompt data never shared and never used to train the models.

Dexit is an intelligent document processing product from 314e Corporation, a healthcare IT company operating since 2004 out of Yardley, Pennsylvania. It is not a clinical inbox tool: the job is reading, classifying and extracting data from unstructured healthcare documents and associating them with the right patient and encounter, and the primary user is health information management staff rather than a clinician. Dexit launched in February 2025. It classifies incoming documents across the 50 to 500 distinct document types a health system typically handles, extracts patient level entities such as name, date of birth and medical record number alongside encounter level details such as dates of service and referring provider, and routes them into the record. In September 2025 the company named the proprietary model behind the extraction, DextractLM, describing it as purpose built for healthcare rather than adapted from a general model, and stated that Dexit runs on self hosted models. 314e publishes two accuracy figures for the product: over 95 percent precision in entity extraction and 97 percent document classification accuracy, the latter attributed to a technique the company calls a Fusion Strategy. Neither figure is accompanied by a test set, denominator or independent validation. The wider company sells both products and services, including EHR consulting, data analytics, integration and revenue cycle management, alongside other products: Jeeves for EHR training, Muspell Archive for FHIR native data archiving and Veritable for eligibility and claims status. This record is scoped to Dexit, which is a separately licensable product rather than a services engagement.

WELL AI Inbox Admin is a fax and document intake product from WELL Health Technologies Corp (TSX: WELL, OTCQX: WHTCF), a Canadian digital health company that operates clinics, owns the OSCAR Pro EMR and sells software to Canadian practices. It is not a clinical inbox tool despite the name: the item being processed is an inbound document, the user is a medical office assistant, and the job is classification, filing and routing rather than composing a clinical reply. The product reads incoming faxes and documents, classifies and names them, extracts patient demographics, assigned provider and insurance details, flags STAT and urgent items for priority attention, surfaces chief complaints, medications and allergies, and routes referrals into the correct provider inbox. It integrates with WELL's own OSCAR Pro EMR and is described as working with other EMR systems, none of which are named. Launched in November 2023 as the third AI product in WELL's suite, following a pilot across six WELL clinics in which more than 16,000 faxes were processed, reported as a 60 percent reduction in time spent on fax handling and roughly 18 hours saved per clinic per week. The market context is specific to Canada and WELL states it plainly. Ontario providers send an estimated 152 million faxes a year and the Ontario Medical Association reports that over 90 percent of doctors still use fax for prescriptions, requisitions and referrals. WELL separately owns OceanMD, whose eReferral, eConsult and eOrder products are designed to replace fax, and WELL's own chief medical officer has said publicly that the company is years away from fax being eliminated. The company therefore sells both the replacement for fax and the tool for coping with it.

Synthpop is an API first, multi agent platform for healthcare administrative operations, not a clinical inbox tool. Its own description of the job is orchestration across the patient journey: referral and document intake, coverage and eligibility verification, prior authorisation, patient communication, and claims and denial follow up, delivered as one coordinated administrative layer rather than as separate point products. The hero workflow in its marketing is referral intake arriving as fax packets and the manual chasing of missing information that follows. Founded in 2023 by Elad Ferber, chief executive, who previously co founded Spry Health and led it to acquisition by ZOLL Itamar, and Jan Jannink PhD, chief technology officer, who co founded imeem and VoiceBase and teaches at Stanford. Headquartered in Cambridge, Massachusetts, previously Wellesley. A 15 million dollar Series A led by Ansa Capital was announced in February 2026, taking total funding to 23 million dollars, with Defy.vc, Peterson Ventures and Storm Ventures participating. The team behind FastStream and FastAgency, who contributed to Microsoft's AutoGen agent framework, joined the company shortly before that round. The company reports processing more than 2 million patients and integration with eight major EHR systems alongside billing and electronic prescribing platforms, and states that its system automates up to 80 percent of the business processes it handles. In April 2026 it was named the first healthcare focused partner agent in the Agent Gallery inside Google Cloud's Gemini Enterprise.

Sample Healthcare sells document processing automation across the administrative span of a healthcare organisation, from patient intake through to insurance appeals, under the name Clinical Reasoning System. It deploys as AI copilots integrating with EMR and revenue cycle systems, claims deployment in days, and reports automating up to 85 percent of correspondence tasks with 2 to 5 times speedups. Customers are described by type rather than name: publicly traded companies and national provider groups, a top diagnostics provider that used it on prior authorisations, and a major health system that increased patient intake capacity. Two things distinguish it and both belong in an evaluation. The first is an engineering grade auditability layer, which is more developed than the norm in this category. The company describes end to end visibility across every dataset, decision and hand off, audit trails that trace any value back to its source, anomaly alerts, and versioned lineage graphs. That is provenance treated as infrastructure rather than as a user interface feature. The second is a statement of intent that almost no vendor in this index makes in public. The company describes its trajectory plainly: it starts by making a team roughly ten times faster, its systems then learn from that team, and eventually they fully automate, with the qualifier that the customer stays in control. Most vendors in this category present human oversight as a permanent design property. This one presents it as a stage, and says the system learns from the people whose work it will eventually take over. That candour is worth crediting and the implication is worth understanding before signing, and it is discussed on the autonomy axis. Evidence is thin. No customer is named, no funding was located, no accuracy figure is published, and parts of the company's own website still carry unreplaced placeholder text, so several axes below are graded low or Not Rated on that basis.

Quench reviews medical records for the medicolegal market, not for clinical care, so it is filed under administrative automation alongside the other insurance and legal record review products rather than under clinical summarisation. Quench SmartChart takes the thousands of page PDFs that arrive in a medicolegal matter, organises them, identifies records that appear to be missing, and produces a chronology of the case. A natural language interface called AskQuench lets a reviewer interrogate the file and returns documented answers, and findings can be saved as the reviewer works and referenced later in a report. Records are reviewed inside the platform rather than in a separate viewer. The founder and chief executive is Michael D. Lesh, a cardiologist and adjunct professor of medicine at the University of California San Francisco who left practice to become a medical device entrepreneur, and the company describes its platform as physician engineered. Two clinical advisers appear on the record with verifiable positions: an associate medical director in enterprise occupational health at the Cleveland Clinic, and the chief of occupational health at a Department of Veterans Affairs healthcare system. Users are physicians and nurses acting as expert witnesses, independent and qualified medical evaluators, law firms and insurance companies, working on workers compensation claims, standard of care questions, defective product injury, litigation, claims disputes and underwriting. The reason this record is worth reading alongside the other medicolegal products is a line the company publishes about what it will not do. Asked whether the AI performs legal tasks, Quench answers plainly that it does not cite cases or draw conclusions, and that the system exists to organise documents, provide a chronology and help a reviewer find relevant information. In a market where a direct competitor markets inference as its differentiator, that is a deliberate scope limitation and it is discussed on the autonomy and governance axes.

Vibrant Practice is not a summarisation tool, it is an AI native electronic health record and practice operating system, and it serves a market nothing else in this index covers: independent clinicians practising functional, integrative and longevity medicine, in concierge, direct primary care and hybrid models across North America and Europe. It is filed here because the clinical AI work it does is synthesis, reading a patient's data and laboratory results and turning them into charting and treatment plans, and cross listed into administrative automation for the intake, scheduling and billing side. The platform automates intake, documentation, appointment scheduling and billing, generates personalised treatment plans from patient data, lifestyle factors and medical history, and includes a patient application providing continuous communication, health tracking and personalised recommendations. Its clinical pitch centres on laboratory work, which is the right emphasis for its market: functional and longevity practice runs on large panels that a clinician must interpret and trend, and the company markets simplified labs, reduced charting time and faster clinical insight. It was founded in 2024 in Sacramento by Sunita Mohanty and Pedro Tabio. Mohanty was previously an AI product leader at Meta working on the Ray-Ban smart glasses and Oculus platforms, holds a Stanford Graduate School of Business degree, and speaks at the Institute for Functional Medicine and A4M. She has publicly argued that human in the loop is the correct approach both for coding and for anything relational or patient facing. The company raised 1.7 million dollars in pre seed funding in March 2025 from Anthemis Group, Dria Ventures, Emerson Collective, Hustle Fund and Lombardstreet Ventures, and sells on subscription. No customer is named, no deployment figure is published, and nothing about models, accuracy or clinical validation was located, so most axes below are Not Rated.

pareIT summarises medical records for the medicolegal market, not for clinical care, so it is filed under administrative automation alongside the other insurance and legal record review products rather than under clinical summarisation. pareIT LLC launched its platform in June 2022 out of Los Angeles, founded by Rami Hashish, who describes a decade as a retained biomechanics expert dealing with medical record analysis as the origin of the product. The platform ingests a case file, removes duplicate and void documents, arranges what remains into a chronological timeline, and extracts diagnoses, prognoses, treatment recommendations, medical history and handwritten records. Outputs include a medical chronology, a full analysis and an executive summary, with an assistant named Paige answering questions against the file. ICD and CPT code extraction is described as a beta capability. The market is broader by case type than the rest of this group. Alongside personal injury and workers compensation it covers medical malpractice and criminal cases, and the company also addresses insurers and health technology buyers. It integrates with Clio, the dominant legal practice management platform. Two things distinguish it. It answers the question this index puts to every vendor and almost none answers, naming the model stack underneath it: the platform runs on Amazon Web Services and uses Amazon Comprehend Medical, with proprietary models the company describes as patent pending and trained on more than a million medicolegal data points. And its original accuracy claim was unusually restrained, stating parity with manual medical record summaries rather than superiority to them, in a market where competitors claim to beat human reviewers. One practical note affecting how much of this record could be verified. The company's own website disallows automated access, so several attributes below rest on third party directories and press material rather than on the vendor's own current pages, and are marked accordingly.

DigitalOwl interprets medical records, but like Wisedocs it is not a clinical product and no healthcare provider buys it. Its users are life insurance underwriters, claims adjusters and lawyers. It is filed under administrative automation rather than clinical summarisation for that reason. The platform turns medical records into chronologies, structured summaries and, since late 2024, inferred case insights. Case Notes is described by the company as using the first AI agents built specifically for insurance medical record analysis, going beyond summarisation to weave together scattered data points, apply business logic and draw conclusions such as whether a condition has progressed or improved. An in depth analysis chat lets a user interrogate the file directly, and a demand package module examines settlement demand letters against the medical and billing data behind them. The company states Case Notes is continuously refined by its own in house underwriters, claims adjusters and legal and medical professionals. Coverage spans life underwriting, post issue audits, property and casualty claims, workers compensation, bodily and personal injury, and mass torts. The post issue audit use case deserves particular attention from anyone assessing this product: it reviews already paid claims for accuracy and identifies whether adjustments should be made to pricing, underwriting or application guidelines, and the platform describes output that maps to rules engines. That is the workflow in which a summarisation error has the most severe consequence for the person whose records were read. One corporate change to note: the company states that DigitalOwl is becoming ChartSwap Insights, combining medical record retrieval and analysis in one platform. Confirm the contracting entity and what changes on renewal. One thing distinguishes it from every other record in this lane. DigitalOwl is the only vendor reviewed here that publishes material on bias and accuracy testing of its own models, and frames transparency, accuracy and fairness as central. That instinct is right and nobody else in this category shows it. The material itself is gated behind a download form and could not be assessed, and the page hosting it carries unreplaced placeholder text, so the claim is recorded as promising and unverified rather than credited.

Zus Health assembles a longitudinal patient record from national data networks and makes it usable. The Zus Aggregated Profile, or ZAP, pulls EHR data from thousands of provider sites through CommonWell and Carequality with TEFCA planned, prescription fill data through Surescripts, and admission, discharge and transfer alerts through PointClickCare and Bamboo Health, then deduplicates, normalises to FHIR, applies consistent terminology and presents the result to a care team. Coverage is stated at more than 320 million patients with a roughly 90 percent success rate matching a patient to data. Identity is resolved by the company's own master patient index, which assigns a Universal Patient Identifier shared across every record believed to belong to the same person. The summarisation layer is real and clinician facing. GPS sits alongside the ZAP overview and gives a structured view of history, problems, medications and unstructured notes tailored to the care model, used by early adopters to accelerate visit preparation, and every summarised point carries a direct link back to the underlying record. Separate enrichments include hospitalisation summaries, which the company says detect 33 percent more admissions and discharges than prior vendors, and medication journey normalisation that groups prescriptions by active ingredient. It is filed under administrative automation rather than clinical summarisation, and cross listed into summarisation, because of what the deliverable is. For a product like Abstractive Health the retrieval exists to feed the summary. Here the summary is one of several ways to consume the data, alongside REST and GraphQL APIs, webhooks and analytics tables pushed into Snowflake, BigQuery or Databricks. Buyers purchase the network and the normalised record; the summary makes it readable. That places it alongside Particle Health rather than alongside the clinician facing summarisers. One architectural detail is worth understanding before diligence. Access to third party data is gated on the customer asserting an active treatment relationship, and where that assertion is absent an organisation sees only the data it contributed itself. That is an access control tied to a legal basis, which is more than most platforms describe, and it rests on customer self attestation.

Wisedocs summarises medical records, but it is not a clinical tool and it is not bought by a healthcare provider. Its customers are insurance carriers, third party administrators, claims adjusters, insurance defence firms, claims legal teams, independent medical evaluators and government claims programmes. The medical record here is evidence in a claim, not a chart used to treat a patient. It is filed under administrative automation rather than clinical summarisation for that reason, and it is not comparable to a product a clinician opens before a visit. What it does is compress the document stack at the centre of injury and disability claims. Files arrive as thousands of unsorted pages: PDFs, faxes, images, handwritten notes and duplicate records from multiple providers. Wisedocs sorts, splits, labels, deduplicates and indexes them into a searchable medical chronology, extracts structured detail including diagnoses and timelines from low quality scans and handwriting, and generates summaries in formats such as SOAP. The platform bundles AI Medical Chronologies, AI Medical Summaries, AI Medical Insights, a conversational interface called WiseChat for interrogating a claim file, and custom reports. The company states the models are trained on more than 100 million real world documents. Two design choices are worth naming. Every summary, insight and risk signal is linked to its source with page level citations, so a reviewer can verify any assertion against the underlying document. And the platform detects co mingled records, meaning pages belonging to a different claimant that have found their way into the file. That is both an accuracy control and a privacy control, and nothing else reviewed in this index does it. Customers are described by type rather than by name: leading United States property and casualty and disability carriers, a Department of Health and Human Services claims programme, and one of the largest state workers compensation insurers in the country. Reported outcomes are 60 to 80 percent faster first touch, up to 70 percent of claims processing automated and up to a threefold reduction in manual review cost, all vendor reported.

Patient privacy monitoring formed by merging two of the category's established products: FairWarning and Maize Analytics, now sold as Imprivata Patient Privacy Intelligence. Indexed under the product-scoping rule, as with ModMed and Indica Labs. Imprivata's wider business is healthcare identity and access management, which would not qualify on AI centrality; this record covers the privacy monitoring product specifically, where the AI is identifiable and gradeable. Corporate lineage: Maize Analytics was acquired by SecureLink in May 2021, SecureLink by Imprivata, and the two privacy products were then combined. The technical idea inherited from Maize is genuinely distinctive and inverts how this problem is normally approached. Conventional privacy auditing hunts for high-risk behaviour in the access log. Maize's Explanation-Based Auditing System instead tries first to explain each access, matching it against a legitimate clinical or operational reason such as an appointment, an encounter, a diagnosis code or a departmental relationship, then flags only the residue it cannot account for. Filtering out what is explainable leaves a far smaller pool for human review than trying to spot suspicious patterns directly. The approach originated in academic research at the University of Michigan by Daniel Fabbri and Kristen LeFevre, was published and peer reviewed with the original paper reporting explanations for over 94 percent of accesses in a real University of Michigan Health System log, and is patented as US 8745085B2. The company reported automatically auditing up to 99 percent of EMR accesses in production. Architecture scales to between 100,000 and one million accesses per minute using a parallelised database, with multiple instances able to share the workload, and deployment runs in a virtual machine inside the customer environment so data does not leave. Maize was ranked Best in KLAS for patient privacy monitoring in 2021. Imprivata states PPI supports both proactive auditing to surface risk before harm and reactive auditing to investigate incidents and complaints, with three years of archived audit trail storage.

On-device runtime protection embedded inside the medical device itself, which is a fourth distinct approach in this category. Network monitoring vendors watch devices from outside, and manufacturer tooling analyses software before shipment; Sternum hardens the device from within so it defends itself while running, including when disconnected from any network. Founded 2018 in Tel Aviv by a team drawn substantially from IDF Unit 8200. The core technology, patented EIV or Embedded Integrity Verification, uses binary instrumentation to place security checkpoints inside the device's compiled code, verifying the integrity of the execution flow, meaning the order in which code runs, and of dynamic memory. The underlying insight is elegant and worth understanding: whatever the vulnerability and whatever the malware, an attacker must ultimately divert the device's intended execution flow to run malicious code, so preventing that diversion blocks the attack without needing to know which specific flaw was exploited. That is why the company can claim protection against unknown and zero-day vulnerabilities and against software supply chain threats in third-party libraries, which matter enormously here because medical device firmware leans heavily on components the manufacturer did not write. Overhead is reported at 1 to 3 percent latency and roughly 10 percent code footprint. Operating at bytecode level makes it broadly compatible across RTOS and embedded Linux environments including Zephyr, FreeRTOS, VxWorks, Micrium and OpenWrt, and it works on legacy devices. Sternum became the Zephyr Project's first embedded runtime security partner under the Linux Foundation. A second capability layer provides fleet observability with AI-driven anomaly detection, log management, remote debugging and root cause analysis, feeding into SOC, SIEM or SOAR tooling. The company positions this explicitly against the patching problem the FBI has highlighted for unpatched medical devices, since runtime prevention reduces dependence on field patching that is slow, costly and sometimes impossible on deployed clinical equipment.

Product security platform for connected device manufacturers, spanning medical devices and automotive. The defining capability is binary-first analysis, and it addresses a problem MedCrypt's approach does not. Most SBOM tooling starts from an SBOM the manufacturer supplies or a supplier provides, which assumes that document is accurate and complete. Finite State derives the inventory from the shipped artifact itself: it automatically unpacks over 130 binary formats across 30-plus architectures, with support cited elsewhere for 50-plus binary instruction set architectures, revealing file systems, libraries and components even inside encrypted or proprietary firmware without requiring source code access. That matters because device manufacturers frequently cannot obtain source for third-party and off-the-shelf components, which is precisely where unknown risk accumulates. Binary software composition analysis extracts function names, control flow graphs and symbols directly from compiled binaries, and binary static application security testing analyses decompiled code for unsafe function calls that could enable denial of service, privilege escalation or full system takeover. The second differentiator is reachability analysis: the platform evaluates call graphs and entry points to determine whether a vulnerable code path can actually be executed at runtime, reported to reduce false positives by up to 80 percent and cut noise by up to 90 percent. The regulatory payoff is concrete rather than theoretical, because unreachable vulnerabilities can be documented as defensible not-affected justifications in audit-ready VEX documents rather than remediated unnecessarily. Generates, imports and enriches SBOMs in SPDX, CycloneDX and VEX formats, ingesting from a reported 120-plus external sources, and maps findings automatically to FDA Section 524B and IEC 62304, extending to the EU Cyber Resilience Act. Offers Health-ISAC members free SBOM generation and firmware risk assessment for three products. Indexed alongside MedCrypt, its closest comparator in the device manufacturer sub-lane.

Patient privacy monitoring from iatricSystems, a healthcare IT company with more than 35 years of integration experience and a reported track record across 1,300 or more hospitals. Haystack iS, formerly Security Audit Manager, consolidates PHI access activity from the EHR, HR systems and hundreds of third-party applications into a single platform so privacy teams monitor, investigate and document in one place rather than running separate audit reports per system. Version 2 launched March 2026, rebuilt rather than incrementally updated, adding customisable dashboards, deeper drill-down into events and investigations, and the ability for privacy teams to adjust event weights themselves so risk scoring aligns with their own policies and risk tolerance rather than a vendor-fixed model. Two named AI components, and the distinction matters. Solomon is the detection engine, evaluating multiple signals rather than a single data point and learning what normal looks like within each organisation including differences by role, department, shift and workflow. AVA, an Advanced Virtual Assistant, automates the follow-up: when potentially inappropriate access is detected it initiates a questionnaire directly with the user, collects the response and returns the context to the privacy team, so auditors spend time on decisions rather than manual outreach. That auto-outreach capability is unique among indexed privacy vendors and deserves scrutiny as well as credit, since the system contacts a suspected employee before a human has reviewed the case. Integration breadth is the standout: named EHR support spans Epic, Cerner, MEDITECH, Allscripts, athenahealth and Quadramed among more than 180 vendors, plus document management systems including Hyland and Perceptive, clinical systems across PACS, pharmacy, lab and radiology, and HR platforms including Workday, PeopleSoft, ADP, Kronos and Active Directory, with an open standard audit file import specification that works with virtually any system generating an audit file. Named customers include Renown Health and WVU Medicine, which runs 23 hospitals and has partnered with the company for over 14 years.

Cyber exposure management platform covering the full cyber-physical systems landscape, with medical device security as one of five products within Armis Centrix alongside Asset Management, OT/IoT Security, ViPR Pro for vulnerability prioritisation and remediation, and Early Warning. The platform correlates device context, behavioural anomalies, vulnerability intelligence, business impact and exposure pathways into a unified risk model, prioritising remediation by real-world operational risk rather than treating findings in isolation. Named a Leader in the 2026 Gartner Magic Quadrant for CPS Protection Platforms for the second consecutive year, one of 13 vendors evaluated, and recognised in the companion Critical Capabilities report, with 119 Gartner Peer Insights reviews in that category rating 4.7 out of 5 as of March 2026. Offers on-premise, cloud and hybrid deployment. Two things a reader must weigh, both stated plainly by the company. First, this is a horizontal platform, not a healthcare specialist: it serves manufacturing, energy, critical infrastructure and government alongside healthcare, and medical device security is one product line rather than the business. It is indexed on the same basis as Claroty, whose Medigate-derived healthcare capability sits inside a broader industrial security platform. Buyers should compare it against healthcare-only vendors such as Cylera and Asimily on depth of clinical device intelligence rather than on platform breadth, and independent Gartner Peer Insights commentary notes that while asset visibility is strong, some users find OT and CPS protocol depth less than top tier. Second, independence is ending: Armis has announced a planned acquisition by ServiceNow expected to complete in the second half of 2026. The company states it will continue operating with the same mission and innovation strategy under ServiceNow investment. That should be treated as a forward-looking statement rather than a settled outcome, and buyers signing multi-year agreements should establish what contractual continuity exists. The pattern is worth watching: an independent exposure management platform absorbed by an enterprise workflow vendor raises the same question as diagnostics manufacturers acquiring open algorithm platforms.

Medication intelligence platform whose ControlCheck product, formerly Bluesight for Controlled Substances, is the market share leader in drug diversion detection. Founded 2011 as Kit Check, rebranded to Bluesight in December 2022, based in Alexandria, Virginia, led by co founder and chief executive Kevin MacDonald and backed by Thoma Bravo. The diversion product connects data from automated dispensing cabinets, electronic medical records and other systems to deliver a 100 percent audit of dispense, administration, waste and return records for controlled substances, flagging discrepancies for review so pharmacy staff investigate real issues rather than manually reconciling records. The stated technical approach is notably specific: unsupervised machine learning with continuous learning, identifying anomalous patterns in clinician behaviour. The company's own explanation of why is the clearest articulation of the AI necessity argument in this category, and it is candid about what it replaces: simple statistics such as standard deviations and averages have proven inadequate against diverters who have become adept at covering their tracks, because diversion patterns are often visible only when many variables are compared simultaneously and evaluated against other patterns. Reported Best in KLAS three years running, with more than 100 million medication transactions tracked and over 1,000 US and Canadian hospitals using Bluesight solutions. Deployment is deliberately low friction: the platform runs on a HIPAA-compliant cloud, leverages existing reports and multiple data delivery options rather than requiring complex integrations, and one health system implemented across 10 hospitals in a reported 33 days with minimal IT involvement. Updated 29 August 2026. The company has grown substantially by acquisition and has folded each acquired brand into its own product line rather than operating it as a standing brand: Medacist in 2023, Sectyr in 2024, and Protenus in January 2025. The patient privacy monitoring product now sold as PrivacyPro is the former Protenus platform, and Bluesight's own announcements refer to it as previously Protenus. In the 2025 Best in KLAS report ControlCheck scored 86.1 in the drug diversion monitoring category and the patient privacy product scored 94.3, among the highest scores recorded in that ranking. The suite now runs to six products: ControlCheck, PrivacyPro, KitCheck for radio frequency identification kit and tray inventory, CostCheck for drug spend, 340BCheck for covered entity compliance which was rebuilt on Sectyr technology and relaunched in April 2026 with a 100 percent transaction audit, and ShortageCheck for shortage forecasting. Prism Assistant, the first product on a new artificial intelligence platform, arrived in 2026 and carries no located governance or model disclosure. Indexed in cybersecurity for the diversion and privacy products specifically, applying the product-scoping rule: the inventory, spend and 340B products are pharmacy operations tools rather than security. Medication safety and prescribing is carried as a secondary category because ControlCheck is a direct comparator to the diversion analytics sold inside the BD Pyxis and Omnicell dispensing estates, and a buyer comparing those three should find all of them.

Healthcare IoT security platform, MedCommand, built exclusively for hospitals rather than adapted from a general IoT product, covering connected medical devices, operational technology and traditional IoT. The technical differentiator is genuinely novel and resolves the central constraint of this category. Medical devices are fragile and cannot be actively scanned while in clinical use, because a vulnerability scan can take a device out of service mid-treatment, which is why every competitor relies on passive network monitoring. Passive observation, however, cannot rigorously test for vulnerabilities, only infer them from observed traffic. Cylera's patented Digital Twin approach resolves that tension: it uses network traffic emulation to construct a virtual replica of each medical device, learning its behaviour agentlessly, and then probes the twin rather than the live device, enabling out-of-band vulnerability detection without ever touching equipment attached to a patient. Machine learning continuously updates the device and vulnerability knowledge base from multiple sources. The platform also automatically identifies zero-day devices and zero-day protocols, meaning previously unknown equipment appearing on the network is flagged proactively rather than sitting unclassified. Capabilities span asset discovery and real-time inventory across managed and unmanaged devices, vulnerability and risk assessment, segmentation, threat detection, and notably device utilisation and fleet optimisation analytics, which serve biomedical engineering and finance rather than security alone. Targets providers with 150 or more beds and multi-facility networks, unified through a central management console. Integrates with Cisco ISE and TrustSec for segmentation enforcement, with the integration maintained in the standard platform at no additional cost or consulting hours. A UK deployment at Dartford and Gravesham NHS Trust pairs Cylera with The AbedGraham Group's clinical risk analysis platform to quantify device risk in terms of patient safety and clinical service impact rather than technical severity alone.

Acquisition update, 29 August 2026. Protenus was acquired by Bluesight on 9 January 2025 and no longer trades under its own name. Bluesight's own announcements describe its patient privacy monitoring solution as previously Protenus, and the product is now sold as PrivacyPro within the Bluesight suite. Under the index rule on acquired vendors this record is retained with the acquisition documented, so that a buyer searching for Protenus finds out what happened to it, and the live vendor record is Bluesight. The grades below describe the platform as researched under the Protenus name and were last assessed on 26 July 2026. The description that follows is retained from that assessment. Healthcare compliance analytics addressing the insider threat rather than the external one, which makes it structurally different from every device security vendor in this category. Two products share one platform and one underlying insight. Patient Privacy Monitoring detects inappropriate access to electronic medical records, and Drug Diversion Surveillance detects theft of controlled substances by staff. The company's founding observation is the reason AI is necessary here rather than decorative: health systems were reviewing only a tiny fraction of patient access logs and similarly tiny samples of controlled substance transactions, because manual audit cannot scale to the volume, which left the overwhelming majority of accesses unexamined. Protenus monitors 100 percent of system accesses and audits 100 percent of medication use transactions. The technical approach is behavioural profiling on both sides of an access event: the platform ingests EHR, HR and automated dispensing cabinet data, builds profiles of patients using demographics, appointment information and procedure and diagnosis histories, and separately builds profiles of the users accessing those records and controlled substances, then reasons about whether a given access was appropriate. The company describes the same platform being trained with different intelligence for the two use cases, since privacy violations and diversion are both workflow anomaly problems. Founded 2014 in Baltimore by CEO Nick Culbertson. Awarded Best in KLAS in 2023 for both patient privacy monitoring and drug diversion surveillance, and named a Gartner Cool Vendor in Healthcare Artificial Intelligence. Holds patents on the diversion technology including US Patent 11,621,065, Methods and Systems for Analyzing Accessing of Drug Dispensing Systems. Reported customer outcomes include 70 percent time savings in case review and an 86 percent decrease in case resolution time. Runs on US-based AWS infrastructure.

Cybersecurity for medical device manufacturers rather than for hospitals, which makes this the only vendor in the index addressing the upstream half of the connected device problem. Where Claroty, Asimily and Ordr help health systems secure devices already deployed on their networks, MedCrypt helps the companies building those devices meet regulatory security obligations before and after market. The regulatory context is what makes this a real category rather than a niche: FDA cybersecurity expectations moved from guidance to enforceable statutory mandate under Section 524B of the Food, Drug and Cosmetics Act via the PATCH Act, with requirements fully effective from October 2023 and a Refuse to Accept policy meaning inadequate cybersecurity documentation can block a submission outright. Manufacturers must submit a Software Bill of Materials, identify known vulnerabilities including those in CISA's Known Exploited Vulnerabilities Catalog, provide safety and security risk assessments per vulnerability, and maintain postmarket monitoring for the life of the device. The flagship product Helm manages SBOM generation, validation and vulnerability tracking across a device portfolio, and its central function is determining which vulnerabilities are actually relevant to a given device rather than listing every CVE matching a component. It draws exploitability intelligence from EPSS, CISA KEV, ExploitDB, Metasploit, NVD and CWE Top 25, applies AI to detect which technology stacks a vulnerability affects in order to suppress false positives, generates short-term mitigations and upgrade paths, and produces FDA-ready SBOM, VEX and VDR reports. Auto-rescoring tracks changes in exploitability and fixability over time. The wider portfolio covers cryptography and device monitoring supporting FDA Secure Product Development Framework implementation. The company publishes substantial regulatory analysis, including work on 2026 FDA premarket deficiency trends, and states it collaborates with regulatory bodies on standards.

Connected device security platform whose distinguishing claim is closing the gap between identifying risk and acting on it, which is the specific failure mode in this category: segmentation projects rarely fail because they lack value, they stall because teams do not trust their asset data enough to enforce policy. Ordr addresses that by generating segmentation policies from observed device behaviour rather than manual templates, simulating enforcement impact before deployment so the blast radius is visible, and validating policies against real traffic patterns. Discovery is passive and agentless, using behavioural fingerprinting the company states is trained on more than 100 million real-world devices and on proprietary device languages from thousands of manufacturers, producing inventory with device make, model, firmware, operating system, clinical function, owner, location and software versions. Risk is prioritised by operational and patient impact rather than CVSS severity alone, correlating CVEs, manufacturer advisories, clinical criticality and network exposure without active scanning. Behavioural monitoring runs continuously to detect anomalies, malware indicators and unauthorised connections, which matters most for legacy and unmanaged clinical devices that cannot run security agents at all. The platform reports protecting nearly two million connected devices, trust from more than 500 organisations across healthcare, banking and manufacturing, and named healthcare deployments including Dayton Children's Hospital and Freeman Health System. Initial discovery is stated to complete within 48 to 72 hours. Ordr IQ is a natural language orchestration layer letting non-technical staff query asset intelligence. Compliance evidence collection aligns to NIST, CIS, HIPAA and PCI. Note on sources: Ordr publishes its own comparative rankings of IoMT security platforms using a proprietary ranking algorithm, in which it places itself among the leaders. That content is factually useful on competitors but is self-interested, and this record relies on it only for the company's own product claims.

Healthcare cyber risk management operating on a fundamentally different model from the device security vendors that dominate this category: Censinet RiskOps is a cloud-based risk exchange where healthcare organisations and vendors share assessment data collaboratively, so the asset compounds with network participation rather than being rebuilt by each customer. Boston based, founded by CEO Ed Gaudet, and an American Hospital Association Preferred Cybersecurity Provider. The scope is third-party and enterprise risk rather than connected devices: assessing the vendors, products and services a health system depends on, spanning medical devices, cloud software, robotics and consulting, with assessments flowing into structured remediation workflows and continuous oversight rather than point-in-time reviews. Reported reach exceeds 1,000 healthcare organisations across a network of over 50,000 vendors and products. Delivery is flexible between fully self-operated, co-managed risk management services, and the on-demand Censinet One model. The 2026 direction is the interesting part for this index. At ViVE 2026 the company set out a Censinet GRC AI vision extending from third-party risk into an AI-native governance, risk and compliance platform, and launched capabilities operationalising the HSCC Sector Mapping and Risk Toolkit framework, mapping vendors to the 17 critical functions underpinning healthcare delivery, with a healthcare-specific FICO-style inherent risk score from 300 to 850, concentration risk and chokepoint visibility to expose systemic dependencies, and network-powered intelligence drawn from the exchange. It also announced AI Telemetry, providing continuous evidence-based visibility into a health system's AI exposure across its third-party ecosystem rather than a point-in-time snapshot. That last capability is notable in context: this is a vendor whose product is partly governance of the AI its customers buy, which makes it structurally adjacent to what this index does. The Change Healthcare attack is the reference case the company cites for systemic concentration risk.

Exposure management platform for connected device environments spanning IoMT, IoT, OT and IT, with healthcare delivery organisations as its founding and strongest vertical. Founded 2017, headquartered in Sunnyvale. The defining capability is contextual vulnerability prioritisation rather than discovery alone, which addresses the problem that actually defeats hospital security teams: a large hospital may run 10,000 to 25,000 connected medical devices representing 30 to 40 percent of all networked endpoints, and a raw vulnerability list across that fleet is unusable. Asimily evaluates each vulnerability in the context of the specific device's configuration and network environment, and prioritises by likelihood of exploitation and clinical or business impact, so remediation effort goes where risk is real. The company states this is necessary because IoT and IoMT devices exhibit network behaviour unlike conventional IT endpoints, leaving general purpose security tools unable to distinguish genuine risk from false alarms. The platform maintains an extensive knowledge base of connected and standalone medical devices, protocols, vulnerability research and manufacturer capability documents, and extends beyond assessment into orchestrated segmentation and risk mitigation, plus pre-purchase device evaluation so risk can be assessed before procurement. Ranked first in the KLAS 2026 Healthcare IoT Security report with a score of 96.6. Also ranked 13th fastest-growing cybersecurity company on the 2023 Deloitte Technology Fast 500 on reported 773 percent revenue growth, and selected for the US Department of Energy Clean Energy Cybersecurity Accelerator. Integrates with CMMS platforms including MediMizer bidirectionally, enriching its machine learning with medical device context while feeding security incidents into maintenance remediation workflows.

Autonomous medical coding engine that assigns ICD-10-CM/PCS and CPT codes from patient charts and routes encounters directly to billing with no human review. The technical approach is deliberately not end-to-end deep learning, and that distinction is the whole record: Nym uses proprietary Clinical Language Understanding built on computational linguistics, combining machine learning models with rules-based clinical ontologies that encode coding guidelines from the AMA, CMS and WHO. The engine reconstructs the clinical narrative of the encounter, then links ontological entities to codes, which is why it handles the failure mode that defeats keyword-based computer-assisted coding, most notably negation, where a note stating a patient does not have a condition must not generate that code. Reports over 95 percent accuracy, with encounters routed to billing when coding confidence exceeds that threshold and charts the engine cannot confidently code returned to human coders. Processes a reported 5.5 million or more charts annually across more than 250 US healthcare facilities, with named customers including Geisinger, Inova, Intermountain Health and OSU Physicians. Coverage began in emergency department and inpatient settings and expanded to outpatient in 2024, with multispecialty support including radiology. Built by an interdisciplinary team of physicians, computational linguists and engineers. The differentiator most worth checking is explainability: every assigned code carries an audit trail stating the logic for why it was assigned, which the company contrasts explicitly with black box AI. That is a substantive claim in a domain where incorrect codes create False Claims Act exposure for the billing organisation. Indexed alongside CodaMetrix, the closest comparator, which takes a different technical approach to the same problem.

Infinitus points voice artificial intelligence in the opposite direction from most of this index. Its agents do not answer patients calling a clinic. They call insurers and pharmacy benefit managers on a provider's behalf, navigate the automated menus, wait through the hold queues and hold a conversation with the representative who eventually answers. It is the specific administrative bottleneck almost no other vendor attacks directly. The work is the traffic standing between a prescription and a patient receiving it: verifying medical and pharmacy benefits, checking whether a treatment requires prior authorisation and whether one is on file, following up on appeals and formulary exceptions, checking claim status, retrieving explanation of benefit documents, and periodically reverifying eligibility for bridge programmes. Structured results are written back to the provider system rather than left in a call log. Two modes are offered: agents complete calls end to end, and a copilot called FastTrack initiates the call and hands a human staff member a live representative, skipping the menu system and the hold. Anything ambiguous routes to a human reviewer before finalisation. The distinguishing asset is a knowledge graph of payer specific behaviour assembled from millions of prior calls, so the agent knows which questions to ask each individual insurer rather than following a generic script. That is what makes automated payer calls tractable at all, given every payer runs a different phone tree and asks for different information. The company further states the graph lets an agent recognise when a representative gives incorrect information and push back in the conversation, correcting the error in real time. Founded in 2019 in San Francisco by Ankit Jain, chief executive and previously at Google, and Shyam Rajagopalan. Funding is reported inconsistently across sources and both accounts are recorded rather than reconciled: one gives roughly $103M across three rounds from investors including Andreessen Horowitz, ARCH Venture Partners, Atlas Venture, GV, Pfizer Venture Investments, RA Capital, SR One and Bill Gates, while another cites GV and Kleiner Perkins with a $51.5M Series C in October 2024. Scale is stated at more than 100 million minutes of healthcare conversation, over five million conversations and support for more than 125,000 providers, with the company claiming to power payer facing conversations for 44 percent of the Fortune 50. Reported performance includes calls completed faster than manual work with up to 10 percent greater data accuracy and a typical 50 percent return. The company states HIPAA and service organisation control attestations. The platform broadened considerably through 2025 and 2026: a Salesforce partnership announced in June 2025 allowing agents to be invoked from Health Cloud, Life Sciences Cloud and Agentforce, an agentic suite for health plan member services in February 2026, Infinitus Studio, a healthcare specific no code agent builder, in April 2026, and Lens, a conversation review engine covering both agent led and human led interactions, in May 2026, alongside a healthcare focused model context protocol server for agent interoperability. Positioned deliberately as a phone automation and agent layer inside the access stack rather than as an electronic prior authorisation network, a hub administrator or a case management platform.

AI-native EHR for mental health practice, and the vendor that repositioned this category's economics. Rather than selling documentation alongside a separate practice management system, Upheal bundles AI notes, scheduling, billing, treatment plans, compliance checking, client portal, forms, payments and a HIPAA-secure telehealth video room into one platform, and charges $1 per session capped at $69 per month per provider with no per-seat fees and no AI add-on. The company frames the model directly as charging for impact rather than for access, meaning a lighter caseload pays less, which inverts the flat-subscription convention. In 2026 it restructured from a Free, Starter and Premium ladder into this usage-based model, and features previously gated at Premium including Golden Thread treatment plans, the compliance checker and advanced analytics were folded into the paid plan. The Golden Thread capability is the clinically substantive differentiator: it maintains the documented continuity between a client's diagnosis, treatment plan goals and session-by-session progress notes, which is precisely what payers and auditors examine to confirm medical necessity, and the system links plan goals to progress notes automatically after each session. The compliance checker flags documentation gaps before submission to reduce clawback risk. Session capture is flexible across the integrated video platform, in-person sessions, text, dictation and manual upload, with over 170 preset note sections, session analytics measuring talking ratio, cadence and sentiment across the session timeline, and an AI assistant that can recall prior sessions and pull treatment plans. Notes export to external EHRs via browser extension and single-click transfer, and the company reports a bi-directional API and participation in EHR integration programmes. Compliance covers HIPAA with a published BAA, PHIPA for Canada, and SOC 2 Type II. Note on categorisation: sources disagree on whether Upheal is an EHR or a documentation tool, because it functions as both depending on whether a practice adopts it wholesale or exports notes elsewhere.

Revenue cycle automation platform for medical groups and digital health companies, built around a single headline metric the company puts at the centre of its own product page: touchless claim rate, the percentage of claims submitted, processed and adjudicated correctly the first time with no manual intervention. The strategic framing is explicit and worth noting, because it distinguishes the company from most of the RCM category. Traditional RCM vendors aim to make manual cleanup work more efficient; Candid aims to prevent the cleanup by getting claims right on submission. The mechanism is a rules engine carrying reverse-engineered payer requirements that are continuously refined, combined with claim autocorrection that validates data pre-submission, with machine learning used to automate the feedback loop between claim insights and systemic rule changes. Customers can author and manage their own custom rules directly, with vendor training offered. The platform is API-first with flexible modern APIs for direct integration alongside out-of-the-box connections, and compiles provider rosters, credentialing data and custom key/value pairs to widen the share of the claims process that can be automated. Founded out of Y Combinator. Reported touchless claim rates and payor net collection rates above 95 percent, revenue growth of nearly 250 percent year over year in 2024, and a $52.5 million Series C led by Oak HC/FT in February 2025 bringing total funding to $99.5 million. Named customers include Talkiatry and Nourish. Holds a SOC 2 report covering security, availability and confidentiality.

Voice based AI purpose built for behavioral health, substance use disorder treatment, and field based care, marketed as CareOps Automation. Natural language processing captures the live session, or a short clinician summary, and produces structured progress notes while extracting clinical insight from the conversation itself. The product line extends past documentation: Eleos Compliance scans eligible progress notes to flag documentation errors before claim submission, Clinical Insights surfaces treatment effectiveness analytics, Eleos Outreach serves field based case managers and community outreach providers, and leadership dashboards report on staff activity, caseloads and population health. Multilanguage support recognises over 150 languages, with notes translated into clinically accurate English. Deployment is EHR agnostic via a lightweight browser embedding rather than a per-EHR build, which the company positions as its structural differentiator. More than 200 organisations reported using the platform. What distinguishes this record in the index is that the evidence is unusually deep for a documentation product and is published in peer reviewed venues rather than asserted: a randomised clinical trial in the Journal of Medical Internet Research, a machine learning study on therapy homework assignment, and a real-world accuracy study across more than 2.83 million micro-dialogues. The company also frames its own product as augmented rather than autonomous intelligence throughout. Sits adjacent to the index's ambient scribe cluster but is graded in behavioral health because the clinical insight and evidence-based-care layer, not the note, is the substantive claim.

Autonomous medical coding platform spun out of Mass General Brigham in 2019, built on coding AI the founding team originally developed inside that health system in 2016. Uses machine learning, deep learning, and natural language processing to translate clinical documentation in the EHR directly into ICD-10, CPT, and related billing codes across radiology, pathology, surgery, gastroenterology, and inpatient professional coding, with a continuous feedback loop from real-time audit. Reported in use at more than 25 provider organizations representing over 200 hospitals and 50,000 providers, and ranked number one by KLAS Research in the Reduce Cost of Care category. Notable in this index as one of the few vendors selling genuine autonomy in a high volume administrative workflow rather than assistive support.

Credentialing, privileging, and provider enrollment platform from Applied Statistics and Management, a family owned company founded in 1982, deployed at a reported 2,000 or more facilities worldwide. Its AI component is Aiva Credentialing, an engine trademarked in 2018 for automating processing and credential verification, which automates primary source verification against databases including AMA, NPDB, OIG, and SAM, gathers and uploads documents, summarizes complex provider histories for committee review, and flags files with potential issues. Named Best in KLAS for Credentialing five consecutive years through 2025. The company publishes an unusually explicit position on the limits of the technology, stating plainly that AI does not make decisions and instead highlights where human attention is most needed.

API-first provider data infrastructure company operating as an NCQA-certified credentials verification organization, certified for all eleven verification services. Integrates with a reported 600 or more primary sources to automate primary source verification, licensing, payer enrollment, and continuous sanctions and expirables monitoring, with a data layer housing more than two million pre-verified NPIs. Its architectural distinction is being built for embedding rather than logging into: RESTful endpoints and webhooks push events such as credentialing completion or provider termination into customer systems in real time, positioning it as infrastructure other healthcare software builds on. AI is applied within the platform for duplicate resolution, taxonomy mapping, address standardization, and pre-submission error detection.

Provider network lifecycle company covering recruitment, contracting, credentialing, and ongoing monitoring for health plans and larger provider organizations, built on a provider data repository the company reports covers more than eight million providers. Distinguished within credentialing by holding both NCQA certification and full three year URAC CVO accreditation, a combination the company states fewer than 25 credentialing organizations nationwide hold. Its data matching algorithms automate primary source verification, and the company claims two of three applications complete without any direct provider input. Positions network development as a strategic function rather than back office administration, which differentiates it from vendors selling credentialing alone.

Cleveland based clinical workforce intelligence company built on a real-time clinician data network spanning a reported 19,000 primary sources and tens of billions of claims and encounters across roughly six million clinicians. Its Clinician Wallet is a vendor-agnostic digital credential wallet letting practitioners collect verified credentials once from primary source issuers and reuse them across employers, which reframes credentialing as portable identity rather than repeated verification. Holds US Patent 12,079,891 for digital credential verification and management. Deliberately integrates with incumbent credentialing platforms including HealthStream CredentialStream rather than replacing them, and extends beyond credentialing into workforce supply and demand analytics.

San Jose company whose Hypercube platform abstracts and reasons over unstructured patient records for chart review, cohort building, and clinical trial prescreening. Its stated technical differentiator is a hybrid approach pairing large language models with symbolic reasoning over a clinical hypergraph, adopted specifically because the company argues pure language model approaches are inadequate for clinical work given hallucination risk. Every answer is traced back to discrete highlighted evidence in the patient's original record, and the platform is cloud agnostic and can be hosted in the customer's own environment so data never leaves. Subject of prospective evaluation at the University of Pennsylvania comparing AI alone, human alone, and human plus AI trial prescreening workflows.

Retrospective risk adjustment and quality platform whose Evidence Validation Engine automates medical record retrieval, parses charts, and populates abstraction fields for coder review, supporting HEDIS quality abstraction and RADV audit submissions alongside risk adjustment coding. Founded in 2009 as a medical record retrieval business and since rebuilt around AI and natural language processing, serving health plans and risk bearing providers across Medicare Advantage, ACA Marketplace, and Medicaid.

Credentialing automation and provider network monitoring platform built around real time primary source verification across hundreds of sources, with continuous monitoring that flags expiring licenses, sanctions, and exclusion list changes. Distinguished by a Salesforce native architecture that lets organizations run credentialing inside their existing CRM rather than a separate system, and by offering both software and NCQA certified credentials verification organization services so customers can bring the function in house or outsource it.

Precision research platform applying AI and natural language processing to structured and unstructured EMR data, including physician notes, pathology, genomics, and lab reports, to match patients and sites to trial protocols in real time. Connects health systems, treating physicians, sponsors, and CROs in a shared ecosystem covering cohort building, site feasibility, patient recruitment, and real world evidence generation. Reports sites finding more than 25 percent additional patients relative to traditional recruitment. Acquired in March 2025 by Tempus AI, a company listed on the Nasdaq, for undisclosed consideration; at the time of the transaction the platform was reported to connect more than 750 provider sites, and the acquirer described the attraction as the integration infrastructure. This record covers the Deep 6 platform. Contracting, assurance and governance questions now run to the parent, and a buyer should establish which entity signs and whether the platform has been migrated onto the parent's infrastructure.

AI care coordination platform that pairs disease detection on imaging with automated mobilization of the treating team, originating in stroke where its LVO product received the first ever FDA De Novo authorization for computer aided triage and notification software. The platform now spans more than 50 FDA cleared algorithms across CT, ECG, and echocardiography covering stroke, intracranial hemorrhage, pulmonary embolism, and aortic disease, deployed at over 1,700 hospitals. Its distinguishing mechanism is the mobile app that alerts and connects specialists rather than only flagging a scan.

Provider network operations platform automating credentialing, payer enrollment, state licensing, privileging, and ongoing compliance monitoring, positioned as an AI operations partner running a real time credentials verification organization. Integrates directly with primary sources including federation and federal databases to verify and monitor credentials, and pairs AI agents with credentialing specialists who review critical stages and handle exceptions. Serves health systems, digital health companies, payers, and provider groups.

Medically specialized AI company whose Synapsis AI platform automates electronic medical record chart review and abstraction, answering specific clinical questions from structured and unstructured records rather than generating summaries. Applied to clinical trial pre screening, observational studies, registry reporting, and quality measurement. Deployed enterprise wide at a major academic health system, with results published in a peer reviewed cardiology journal.

Revenue cycle management platform built for dental service organizations, automating insurance claim follow up, explanation of benefits retrieval, payment posting, and accounts receivable analytics. Its InsideDial product uses AI to place payer phone calls and retrieve claim status, denial reasons, and payment details, auto generating verified records rather than leaving staff on hold. Combines AI with robotic process automation and syncs daily with practice management systems and payer portals.

Clinical trial platform that deploys AI matching inside provider EHRs to identify trial eligible patients within routine care, combining structured data prefilters with large language models that reason over full text clinical notes and nuanced eligibility criteria. Pairs the technology with recruitment coordinators working alongside site teams, plus site feasibility automation and a trial design service for sponsors. Operates a research ready provider network spanning community oncology practices, health systems, and academic cancer centers, described by the company as covering roughly 2,100 care locations across the United States, Japan and Israel. Its Study Conduct platform uses source linked electronic case report forms with integrated source viewers, so monitors validate data against the originating clinical record. In April 2026 the company announced a research collaboration with the United States Food and Drug Administration under which trial data is analysed and key safety and efficacy signals are reported to sponsors and to the agency in near real time, already operational in a Phase 2 and a Phase 1b trial, with Amgen and AstraZeneca the first sponsors to join; the company describes itself as the sole technology provider operationalising the agency's Real-Time Clinical Trials proof of concept studies. It also announced a partnership with the contract research organisation Parexel in late 2025. Founded and led by Kent Thoelke, previously Chief Innovation Officer at ICON and Chief Scientific Officer at PRA Health Sciences; incubated by ARCH Venture Partners.

Patient access platform embedding AI agents and unified patient context into healthcare contact centers, integrating bidirectionally with EHR and CCaaS systems so agents see live patient data and outcomes write back to the record. Covers scheduling, billing, referrals, nurse triage, pharmacy refill, transfer center, and operator console workflows, with AI agents handling inbound and outbound interactions alongside human staff. Founded 2005 and healthcare focused throughout, with a proprietary framework that extracts EHR decision logic as the platform's foundation.

Payer intelligence platform whose Smart Response engine analyzes hundreds of millions of claims transactions to learn payer specific rules and adapt to changing payment behavior, predicting claim line payment amounts and denial reasons in real time before submission. Three applications cover prediction, detection of emerging denial patterns, and recovery of unresolved denials. Distributed both directly and through a national health information network under a white labeled name.

Medication access and financial navigation platform that identifies financially at risk patients, matches them against a large network of financial assistance and manufacturer programs, and automates enrollment inside health system workflows using live EHR data. Combines a care team facing platform, a patient facing self serve experience, and a tech enabled service arm pairing automation with human navigators. Serves health systems, oncology practices, infusion centers, pharmacies, and life sciences companies.

Deep learning MRI image enhancement company whose SwiftMR platform applies AI after image acquisition to remove noise and blur, enabling up to 50 percent scan time reduction or improved image quality at existing scan times. FDA 510(k) cleared and deliberately vendor neutral, working across scanner manufacturers, field strengths, and body parts, including alongside the scanner makers' own deep learning reconstruction pipelines. Seoul based with US operations, reported at more than 1,700 imaging centers and hospitals across over 40 countries.

Conversational AI platform whose agents handle inbound and outbound patient communication across voice, text, and web chat: answering calls, booking appointments, running new patient intake, answering insurance questions, taking refill requests, following up after visits, and handling recall and billing outreach. Built for multi location medical groups and outpatient specialty practices, integrating with EHR, practice management, and CRM systems. HIPAA compliant and SOC 2 Type 2 certified.

AI chart review platform that runs a pre bill review across every patient encounter rather than a retrospective sample, coding each visit from provider documentation, flagging missed revenue and compliance gaps while charts are still open, and either autocorrecting in the EHR or queueing problem charts for human review. Built on large language models with each implementation customized to replicate the reviews a client would ask a human reviewer to perform, in contrast to rules based NLP engines.

AI enabled value based care enablement platform for health systems and clinically integrated networks, combining a proprietary predictive model with virtually embedded Healthguides, medical assistants trained in data science who work under licensed clinical supervision to extend care team reach. The platform identifies high risk patients, coordinates referrals and prior authorization, and supports performance in risk based contracts. Formed in 2023 and built partly on the acquired value based care services division of an analytics vendor.

All in one cloud dental practice management platform covering charting, imaging, insurance, payments, and patient communication, now shipping a native AI layer under the Archy Intelligence banner. Archy Scribe generates clinical notes from inside the practice management system with access to the chart and treatment plan before recording begins, voice charting handles perio exams, and FDA cleared dental imaging AI is embedded through a third party partnership. Evaluate as a dental PMS adding AI rather than an AI native vendor.

Specialty specific cloud EHR and practice management vendor, formerly Modernizing Medicine, serving eleven medical specialties through its EMA and gGastro platforms. Its AI layer includes ModMed Scribe, an ambient documentation tool trained on de identified data sampled from a stated 750 million patient encounters, plus a set of AI assistants for scheduling, eligibility processing, prior authorization, and claim denial appeals. Evaluate as an EHR vendor adding AI rather than an AI native platform.

Hospital operations automation platform applying machine learning, generative AI, and behavioral science to predict operational bottlenecks and act on them inside the EHR. Three solution lines address inpatient capacity and discharge planning, perioperative care coordination, and surgical growth and operating room utilization. An AI Solution Factory lets health systems co develop custom operational assistants for additional workflows.

AI native medication access platform, formerly Tandem AI, that automates the path from prescription to patient: prior authorization generation and submission, appeals, pharmacy routing, benefits verification, and patient affordability programs. The platform is embedded at the point of prescribing in the EHR rather than activated after a claim is denied, and is offered free to providers and patients with monetization on the manufacturer and life sciences side.

AI patient billing and revenue cycle platform focused on the patient responsibility portion of provider revenue, which the company notes has risen from roughly 5 percent of provider revenue in 2010 to about 20 percent today and is projected toward 30 percent by decade end. Billie is the AI billing agent, engaging patients across chat, text, email, and voice to answer billing questions, explain what is owed, and take payment, with the company stating it handles the majority of cases and staff step in for exceptions. The platform covers intelligent statements, personalized outreach, payment plans, card on file, autopay, and refunds, plus an eligibility and benefits agent. Positioning is deliberately complementary rather than displacing: the company frames the EHR as the system of record and itself as the system of action on top of it. Integrated with more than 20 leading EHRs via API or FHIR, with a bidirectional Epic integration listed in Connection Hub on the Epic Showroom as of July 2026. Reported footprint is more than 3,000 healthcare facilities with over $1 billion in patient payments processed. Customer reported results include collections increases in the 75 to 300 percent range and average days to collect as low as 12.6. Holds HIPAA, SOC 2 Type 2, PCI DSS, and HITRUST i1 compliance. Backed by Sapphire Ventures and Y Combinator; CEO and co-founder Levon Brutyan.

AI orchestration platform for provider side revenue cycle, founded 2022 and built around the payer relationship rather than internal workflow alone. The company frames itself as an autonomous intelligence overlay rather than a replacement system of record, continuously monitoring aged accounts receivable, commercial denials, and shifting payer behaviour. Two product lines work together: Adonis Intelligence provides detection, alerting, denial clustering, smart worklists, and analytics, while AI Agents execute, navigating third party payer portals to run real time medical necessity and authorization checks, extracting unstructured clinical notes from the EHR to draft and file appeal letters, and progressing claims to resolution. Reported automation covers more than 70 percent of standard claim statusing and appeals tracking routines with a stated 20 to 30 percent reduction in long term revenue cycle operating spend. Available through the Epic Connection Hub. Mount Sinai Health System is a named customer using the platform to identify and prioritize billing exceptions, and Fox Valley Orthopedics reported recovering nearly $200,000 in denials. The company publishes an annual State of Revenue Cycle Management benchmark report, whose 2026 edition found payer denials and reimbursement pressure had overtaken staffing as the primary threat to revenue performance. More than $95 million raised including a $40 million Series C in March 2026; co-founder and CEO Akash Magoon.

Oncology AI reading the full patient chart, founded 2021 on the observation that while software could already handle the roughly 20 percent of medical data that is structured, generative AI made the other 80 percent, the free text notes, tractable. OncoLLM is the underlying platform and the architecture is disclosed with unusual specificity: not one model but a constellation of eight specialized models ranging from 3 billion to 72 billion parameters, working agentically to interpret information at the patient level. Prism is the trial matching application, screening patients with upcoming appointments against all active trials and working in both directions, patient to trial and trial to patient, with continuous tracking. Matches are cited back to pathology, biomarkers, and note level evidence rather than returned as a bare recommendation. The platform has expanded beyond matching into verifiable patient summaries for visit preparation, cancer registry abstraction, and structured data generation for research. Reported results include a 40 percent increase in trial matches, more than 30 percent increase in enrollments, and 67 percent reduction in chart review time, with one NCI designated center reporting 100 percent screening coverage at three times the throughput of manual review. Peer reviewed validation has appeared in Nature Digital Medicine with presentation at ASCO, and a pilot study at the Medical College of Wisconsin Cancer Center covers gastrointestinal, genitourinary, breast, and thoracic teams. Mount Sinai Tisch Cancer Center deployed Prism in January 2026, becoming the first NCI designated Comprehensive Cancer Center in New York City to use it for systemwide matching. More than $36 million raised; co-founders Sarim Khan and Hrituraj Singh.

Generative AI for the provider side revenue cycle, formerly Alpha Health. Unified Automation is the platform: a single engine spanning coding, clinical documentation integrity, prior authorization, and claims, designed to sit on top of existing EHR systems rather than replace them. The architectural argument worth understanding is how it differs from robotic process automation. Rather than recording and replaying screen interactions, which break whenever a payer updates a portal, the company trains models on the behaviour of payer portals, EHR interfaces, and clearinghouse connections so they tolerate interface changes. Modules include Coding Optimizer surfacing missed CPT and ICD-10 codes and compliance risks, CDI Optimizer flagging ambiguous diagnoses and missing specificity, Authorization Advisor handling prior authorization submission and payer specific requirement matching, Auth Status and Claim Status polling payer portals and writing results back to the EHR. The company describes an expert in the loop design that autonomously handles high confidence encounters and escalates edge cases to revenue cycle staff. Models are reported as trained on more than 43 million clinical documents. Reported footprint spans more than 650 hospitals and 6,500 outpatient facilities across all 50 states, with a strategic collaboration with Cleveland Clinic announced to launch revenue cycle AI tools. Customer reported results include a 13 percent reduction in accounts receivable days and 300 or more staff hours saved monthly. Headquartered in South San Francisco; more than $200 million raised.

Health benefits navigation and care platform for self insured employers and health plans, indexed for its AI navigation layer with the surrounding care services as context. WayFinding is a generative AI experience launched in 2024 and scaled through 2025, combining benefits navigation, clinical guidance, and care access in one interface, delivering tailored recommendations from a member's own history so a member can determine what is covered, what it will cost, and where to go. Agentic capabilities were added in January 2026. The company completed a $621 million merger with Accolade in April 2025, taking the formerly NASDAQ listed company private and combining WayFinding and the Cancer Care, Surgery Care, Weight Health, and pharmacy benefit experiences with Accolade's health advocacy, expert medical opinion, virtual primary care, and its True Health Actions platform, which draws on employer data, health plan data, and electronic health records for targeted guidance. The combined organization reports serving more than 20 million members across more than 1,700 employer and health plan clients. Buyers should be clear that this is a hybrid: a substantial share of what is delivered is human advocacy, virtual clinical care, and second opinion services rather than AI. A $126 million Series D in May 2024 was raised specifically to build AI capability. Led by Glen Tullman.

Indexed for the AI capabilities inside the Doctolib platform rather than for the platform itself, which is context under this index's product scoping rule, and the first non US vendor treated this way. Doctolib is the dominant digital health infrastructure provider across France, Germany, and Italy, spanning appointment booking, practice management, and clinical records. Its ambient documentation capability, the Consultation Assistant, is built on technology from the June 2024 acquisition of Typeless, an EPFL and Idiap Research Institute spin off specializing in AI speech recognition, and uses large language models to convert spoken doctor patient dialogue into structured medical text including clinical notes and doctor letters. In November 2025 the company launched an all in one practice management product incorporating three AI assistants, including a telephone assistant that answers calls around the clock, categorizes inquiries, and transfers appointment bookings directly into the Doctolib system; the company reports practices can save up to ten hours per week on administrative tasks. That product launched for general practitioners, pediatricians, and gynecologists with additional specialties planned. The strategic significance is distribution: ambient documentation delivered inside the appointment and record workflow a practice already uses, which is a different competitive position from standalone scribes such as Nabla or Abridge. Note that European regulators treat ambient scribes as software as a medical device, with the UK MHRA classifying them accordingly, so regulatory posture differs from the US market.

AI intelligence platform for life sciences medical affairs, scientific communications, and drug safety, which places it on the medical rather than commercial side of pharma and distinguishes it from vendors excluded from this index for pharmaceutical marketing. The Sorcero Intelligence Platform reads across a reported 263 million publications and 1.3 billion citations globally alongside congress sessions, reports, surveys, CRM interactions, safety cases, and medical inquiries, identifying which key opinion leaders and clinicians are active in specific research areas or treating relevant populations. Sorcero Medical serves medical affairs, with Field Medical Excellence and Insights including an iPad capture app and Congress Intelligence with scientific abstract integration, both introduced March 2026. Sorcero Safety, built with Springer Nature, covers literature and adverse event monitoring for pharmacovigilance. Sorcero MedTech came from the July 2025 acquisition of Axiom Health, extending the platform to medical device real world data and making it a unified platform across pharmaceutical and device organizations. The company describes a trust first approach with hallucination prevention and validated outputs, and an agentic architecture using specialized agents to validate medical information. Reported adoption is a third to 40 percent of the top 30 global pharmaceutical companies. Named a Leader in AI enabled pharmacovigilance software by CB Insights alongside IQVIA, Veeva, and Oracle. Six foundational medical AI patents; 2025 Google Cloud Partner of the Year for Healthcare and Life Sciences. $59 million raised in total including a $42.5 million Series B in November 2025. Co-founded and led by Dipanwita Das.

Payment accuracy and integrity for health plans, and the oldest company in this index by founding date: it began in 1989 and its pre payment editing engine is the former ClaimsXten, with over 30 years of rules and policy content behind it. That history matters to the AI question, because the machine learning sits on top of an established rules engine rather than replacing it. Lyric42 is the orchestration platform, coordinating payment decisions across rules, workflows, policy, and payment accuracy products, and designed to let a plan run a multi vendor strategy through one integration to core systems. Replay is the audit automation engine, using AI to prioritize high impact claims and automate DRG validation, coordination of benefits review, and itemized bill analysis, with the company reporting up to 3x productivity and 4x findings for internal audit teams while reducing dependence on external vendors. LyricIQ provides the analytics layer. The stated framing is decision intelligence producing payment decisions that are independent, verified, and explainable, applied before disputes and rework enter the system. Named 2025 Best in KLAS for Pre payment Accuracy and Integrity, and reports serving more than 100 payers. Headquartered in Newtown Square, Pennsylvania.

Patient financial experience platform for hospitals, health systems, and physician groups, covering the part of revenue cycle the patient actually experiences: the bill. Cedar Intelligence is the AI decision engine personalizing billing journeys across channels, and Kora is the voice agent, launched April 2025 and developed with Twilio, trained on the company's proprietary billing data rather than a general model. Kora resolves common billing inquiries on first contact, explaining charges, identifying payment options, and connecting patients to financial assistance, with sentiment and tone detection, multiple language support including Spanish, and escalation to a live agent with full context when human judgment is required. One year in, the company reports Kora has handled nearly 400,000 patient calls across ten provider organizations spanning Epic and Cerner health systems, physician staffing groups, and large specialty groups, with Gastro Health alone accounting for more than 60,000 calls since September 2025. Kora Outbound extends the agent to proactive engagement of harder to reach patients. The company reports its platform data foundation exceeds one billion patient interactions. Its own published research is unusually pointed for a vendor: 40 percent of collectible dollars on its platform now come from uninsured patients, up 54 percent in three years, and it argues that billing experiences designed for financially stable patients are failing those under the greatest strain.

Health data interoperability API with an AI enrichment layer on top. The base capability is retrieval: a single bidirectional API querying national health information networks including CommonWell, Carequality, and eHealth Exchange plus ADT feeds and prescription data, reaching a reported 320 million patient records across more than 70,000 healthcare organizations, with the company stating it locates roughly 90 percent of patients nationally. The Particle Insights Platform is where the AI sits, built on three stated pillars: enhanced data quality through parsing that surfaces critical elements, enrichment by integrating additional sources, and usability through normalization and deduplication. Snapshot applies AI powered summarization to condense retrieved records, and the company has built an AI discharge summary product. Its published engineering writing is unusually candid about the underlying problem, describing why template based CCDA parsing loses clinically important medications and why identity resolution rather than event delivery is the real failure mode in discharge alerting. Buyers are health technology companies, telehealth and remote monitoring vendors, care management organizations, and payers rather than provider organizations directly.

Indexed for the AI capabilities inside the Veeva Vault platform rather than for the platform itself, which is context under this index's product scoping rule. Veeva (NYSE: VEEV) is the dominant software platform for life sciences, spanning clinical, regulatory, safety, quality, medical, and commercial, with customers including Novo Nordisk, Gilead, Bristol Myers Squibb, Merck, Roche, Moderna, and BioMarin. Veeva AI Agents became available in December 2025, initially for Vault CRM (Free Text Agent flagging issues in call notes, Voice Agent for spoken input, Pre-call Agent assembling context) and PromoMats (Quick Check Agent scanning promotional content against brand and regulatory guidelines before medical, legal, and regulatory review, and Content Agent assisting reviewers). Agents are built on large language models from providers including Anthropic and Amazon, hosted on Amazon Bedrock but operating inside the Vault environment, accessible through the Vault interface or API and customizable through Veeva's AI framework. Safety and quality agents are reported live, with clinical and regulatory agents tied to the 26R2 release. Availability matters here and is stated rather than blurred: two further announced product lines are not yet available. Falcon, a separate platform for standardized agentic labor covering trial master file intake, safety case processing, and health authority interaction management, targets late 2026 for early adopters, and Agentic Authoring, which drafts submissible regulatory documents, is expected in late 2027. Neither is indexed as a shipping capability.

Prior authorization decision support for health plans and pharmacy benefit managers, the third payer side vendor in this index alongside Cohere Health and Alaffia, and the one weighted toward pharmacy benefit rather than medical. BanjoPA automates the end to end workflow: the CARE engine extracts information from faxed or digital prior authorization requests, validates and maps it to case fields, then matches the case against the payer's own clinical criteria. The distinguishing technical step is that CARE transforms dense clinical guidelines into decision trees, converting narrative coverage policy into an executable structure, and the platform reads prescriber notes directly from the EHR rather than relying on manual data entry or fax and phone follow up. The company states its model matches each request against the specific payer's rules rather than applying generic AI, and that every AI generated recommendation carries detailed evidence and an explanation. BanjoA&G extends the same approach to appeals and grievances. Positioned around CMS-0057-F interoperability and prior authorization compliance. Holds HITRUST r2 certification. Named implementation with Navitus, a large transparent pass through PBM owned by SSM Health and Costco serving over 18 million lives, expanded across employer and health plan lines including Medicare and Medicaid in December 2025. Founded by Saar Mahna.

Conversational AI agent platform built for healthcare since inception rather than adapted to it, spanning call centers, websites, SMS, and mobile apps. The architecture is deliberately hybrid: large language models combined with a proprietary conversational engine, small language models tuned for healthcare, and knowledge graphs purpose built for the domain, which the company positions as more controllable than a general model alone. Agents integrate through API into EHRs and CRMs to complete tasks autonomously, including registration, routing, scheduling, and prescription refills, with contextual transfer to a live human when needed, and all interactions captured in a Patient Intelligence Dashboard. The company reports resolving up to 85 percent of routine patient interactions, deployment across more than 45 to 50 US health systems, and over 30 million patients engaging with its agents. Named clients include Intermountain Health, Baptist Health, Hackensack Meridian Health, and Bon Secours Mercy Health, which also invested. Founded 2018 by Israel Krush and Rom Cohen as a Cornell Tech spinout with offices in New York and Tel Aviv; $95 million raised in total including a $45 million round in October 2025 led by Healthier Capital with ServiceNow Ventures participating. Named to Fierce Healthcare's Fierce 15 for 2026.

Clinical intelligence platform sold to health plans, spanning utilization management, payment integrity, appeals, care management, and policy management. The company states it is sold to health plans, and that providers and manufacturers do not license the platform, which makes it payer side alongside Alaffia. Cohere Unify combines a reported 350 or more clinically trained AI models with workflow automation and human review to auto determine prior authorization requests in real time, and Cohere Connect provides the prior authorization APIs, reported to have carried more than 15 million submissions and to support 47 million payer provider interactions annually. The critical design fact is the direction of automation: the company reports up to 85 percent real time approvals and states explicitly that remaining submissions are reviewed by a clinician before final determination, meaning the model approves and humans decide the rest. Additional products include Cohere Review Assist for acute inpatient care, Cohere Policy Studio, and a Payment Integrity Suite extended through the September 2025 acquisition of ZignaAI. Reported outcomes include care access 70 percent faster than traditional processes, up to 9x return on investment, 94 percent provider satisfaction, and a provider NPS of 67. Named plan relationships include Humana and Geisinger. $90 million Series C in May 2025.

AI agent platform for healthcare operations, spanning patient access, revenue cycle, and care operations rather than a single workflow. Agents automate patient intake and registration, appointment scheduling, insurance eligibility verification, prior authorization, denial management, patient payment estimates, referral processing, and post visit follow up, each running a defined workflow end to end. Flow Builder is a no code interface that lets an organization's own IT and non technical staff build, train, and deploy agents, which places it alongside Bunkerhill and XCaliber as a build your own platform rather than a fixed product set. Integration is unusually pragmatic and is the stated differentiator: the company uses whichever method reaches the field, including APIs, RPA, and HL7, reading and writing structured and unstructured data across Epic, Oracle Health, MEDITECH, athenahealth, and payer portals. Named health system deployments include Intermountain, Trinity Health, and MUSC. Published customer results include a health system reaching 64 percent voice containment with roughly $360,000 annual savings, and an insurance FAQ voice assistant answering all inbound calls at a stated $4 saving per call. Backed by Greylock and ICONIQ Growth.

Agentic patient services platform for pharmaceutical manufacturers, automating the post prescription access journey that determines whether a prescribed therapy ever reaches the patient. Named agents handle distinct functions: a consent agent manages opt in for sharing patient health information across manufacturers, specialty pharmacies, and provider hubs; a marketing agent personalizes educational outreach from multi source data; and an enrollment agent accelerates virtual hub enrollment by automating document verification, form completion, and payer navigation around the clock. Ships modular pre configured solutions including automated annual reverification, digital enrollment, bridge to copay sweeps, and click to agent conversational interfaces. The company positions itself as an alternative to traditional labor intensive hub models, where enrollment and reverification are handled by large human teams. Formerly Lifelink Systems, founded 2015; Precision AQ made a strategic investment in 2025 and named an incoming chief executive.

AI native revenue operations platform for post acute care providers including home health, hospice, home care, and nursing homes, a segment the larger revenue cycle vendors largely do not serve. Automates the referral to reimbursement cycle across revenue assurance, smart intake, authorization autopilot, billing operations, and platform intelligence. The model identifies upstream data, documentation, and coverage risk inside the EMR to prevent denials before submission, centralizes and auto extracts referrals arriving by fax, email, and portal, automates prior authorizations from submission through renewal, and resolves claims to cash through posting, reconciliation, and prioritized denial follow up. Routine work is automated while exceptions surface to human billers who make the decisions. Voice agents for insurer information requests are in development. Founded 2025 by Kevin Calcado and JJ Ram; $4.4 million seed in January 2026 led by Maverick Ventures with Peak XV, Y Combinator, and executives at large post acute providers participating.

Agentic AI for health plan claims operations, and the only payer side vendor in this lane: the buyer is the plan rather than the provider. Covers the full claims lifecycle across payment integrity, utilization management, and appeals. Proprietary optical character recognition digitizes unstructured itemized bills and medical records, agents extract and structure clinical facts and cross reference a claim against the complete patient record, clinical criteria, and policy guidelines, automating routine cases and prioritizing high value claims for human review. A generative assistant helps reviewers summarize records, source guidelines, and draft determination responses. The company states it deliberately avoids black box denial algorithms: every recommendation carries a clinical rationale and traceable citations, and licensed clinicians validate and sign off. Maintains SOC 2 Type II, HIPAA, and HITRUST. Reports saving health plans more than $120 million, over 20 percent average savings on high cost facility claims, and go live in roughly 30 days. Founded 2020 by siblings TJ Ademiluyi and Adun Akanni; $55 million Series B in February 2026 led by Transformation Capital, bringing total funding above $73 million.

Agentic operating system positioned as a coordination layer across the systems a provider already runs rather than a replacement for them, on the premise that health systems accumulated EHRs, billing platforms, and scheduling tools over two decades without ever acquiring a layer to coordinate between them. Merlin is the role based agent line, and Patient Navigator, the first shipped agent, spans scheduling, prescription refills, outreach, intake, referrals, prior authorization, and billing resolution. The architecture is deliberately semi autonomous: agents run routine administrative workflows end to end and act across silos in real time, while a human in the loop structure keeps teams in control of critical decisions, with the degree of autonomy varying by whether a task is operational or clinical. The platform blends generative AI with traditional machine learning and microservices so deterministic tasks stay deterministic. Reports processing more than 8 million chart updates and generating over 160,000 EHR updates daily across more than 700,000 unique patients, with the navigator agent saving providers an average of six hours of manual work per day on refills alone. EHR integrations include Epic, Cerner, athenahealth, and eClinicalWorks, with listings on the athenahealth and AVIA marketplaces. Led by co founder and CEO Prakash Khot, previously a co founder of Skyflow; $6.5 million seed announced May 2026. Headquarters is reported as Andover, Massachusetts in funding announcements and as Plano, Texas by Crunchbase; this record does not resolve the discrepancy.

Indexed for the AltitudeAI product suite rather than for the underlying revenue cycle platform, which is treated as context under this index's product scoping rule. AltitudeAI, launched January 2025, brings the company's AI capabilities under one brand across a cloud based RCM platform serving a reported one million providers and processing more than six billion transactions annually, reaching roughly half of US patients. AltitudeCreate applies generative AI to autonomously draft appeal letters for denied claims, drawing on a library of more than 1,100 payer specific appeal templates. AltitudePredict uses predictive analytics to score and prioritize denied claims by expected cash value and likelihood of being overturned. AltitudeAssist, in Claim Manager, converts user prompts into automated denial prevention recommendations that fix issues before submission, which the company reports compresses a three day process to roughly three minutes. The company reports early AltitudeAI results of appeal package creation three times faster, saving about 16 minutes per package. Publicly traded (NASDAQ: WAY). On 1 October 2025 Waystar completed its acquisition of Iodine Software for a total of about 1.25 billion dollars, roughly half cash and half stock, from shareholders led by the private equity firm Advent International. Iodine brought clinical documentation integrity, utilisation management and pre bill review to a company whose own assets were financial, and Waystar described the combination as uniting one of the largest financial datasets in the industry with one of the largest clinical ones. It stated the deal added more than 1,000 hospitals and health systems and expanded its addressable market by over 15 percent. Iodine continues to trade under its own name and holds a separate record in this index; this record remains scoped to AltitudeAI.

Patient communications platform with AI virtual agents across voice, text, and web, formerly WELL Health. Not to be confused with ArteraAI, a separate prostate cancer AI company at artera.ai. The Harmony platform coordinates agentic AI across the patient journey with staff able to take over at any point and full conversation history retained, covering self scheduling, intake, forms, referrals, and billing questions. Flows Agents apply natural language understanding to automate multi step patient conversations, and AI Co-Pilots assist staff with translation, message shortening, and conversation summaries. The company reports more than 1,000 provider organizations including specialty groups, federally qualified health centers, large IDNs, and federal agencies, roughly 2 billion communications annually across 109 languages, and engagement with 100 million patients a year. Artera Government Solutions serves the Department of Veterans Affairs, Department of Defense, and Indian Health Service sites. In May 2026 the company introduced an AI services model pairing the platform with its own build teams. Raised a $65 million growth round in December 2025.

Automates HIPAA Expert Determination, the statistical de-identification standard that governs whether a health dataset can lawfully be used for analytics, research, or model training. The platform detects and remediates PHI entities in structured and unstructured data, assesses re-identification risk, and produces a signed determination opinion from qualified statisticians, an approach the company describes as expert in the middle: automated analysis with human certifier sign off. Unlike Safe Harbor, which strips 18 fixed identifiers, Expert Determination is scoped per dataset and preserves more analytic utility. For AI training corpora the platform replaces real PHI with synthetic entities rather than redacting, so text remains natural for model training. Deploys inside the customer's VPC, on premises, or air gapped environment as container images. Originated in healthcare and is extending the same methodology to financial, consumer, and AI training data, which buyers should weigh when assessing healthcare specific depth.

AI platform for inbound healthcare document and referral operations. RaeLM, the company's proprietary vision language model, reads unstructured inbound material including faxes, scanned forms, and handwritten documents, extracts the clinical and administrative data, and evaluates it against payer criteria to flag likely denials before submission. The vendor reports RaeLM was trained on more than 100 million anonymized healthcare documents, 2.3 billion data fields, and 8,000 sets of payer criteria, and that the platform processes more than 10 million documents a month for over 150 healthcare organizations. Tennr Network gives referring providers, receiving providers, and patients shared referral status visibility. Voice AI for referral phone workflows was added in 2026. Raised $162 million total, including a $101 million Series C led by IVP in June 2025 at a $605 million valuation.

No code AI workflow automation for pharmacy and healthcare operations, with a center of gravity in 340B program compliance. The platform screens 340B eligible claims, uses language models to investigate unstructured EHR data for referral based savings, and automates rebate reporting, Maximum Fair Price reconciliation, intake, and prior authorization. Referral Agent, launched June 2026, is positioned by the company as the first AI agent purpose built for 340B referral capture. The vendor reports customers including Tampa General Hospital, Renown Health, and Salinas Valley Health, more than 100 healthcare organizations on the platform, and customer reported reductions in manual work of up to 97 percent. Founded by Joy Liu, previously an operator at a health system specialty pharmacy company. Raised a $50 million Series B in 2025.